<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.wikidoc.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Rachita+Navara</id>
	<title>wikidoc - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://www.wikidoc.org/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=Rachita+Navara"/>
	<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php/Special:Contributions/Rachita_Navara"/>
	<updated>2026-04-19T05:18:41Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.45.1</generator>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury&amp;diff=1677848</id>
		<title>Drug induced liver injury</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury&amp;diff=1677848"/>
		<updated>2020-12-10T16:23:44Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{See Also|Hepatotoxicity}}&lt;br /&gt;
{{See Also|Hy&#039;s law}}&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;For patient information, click [[Drug induced liver injury (patient information)|here]]&#039;&#039;&#039;&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
{{SK}} DILI; Drug-induced liver injury; Drug induced hepatitis; drug induced liver toxicity&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury historical perspective|Historical Perspective]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury classification|Classification]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury pathophysiology|Pathophysiology]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury causes|Causes]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury differential diagnosis|Differentiating Drug Induced Liver Injury from other Diseases]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury epidemiology and demographics|Epidemiology and Demographics]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury risk factors|Risk Factors]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury screening|Screening]]==&lt;br /&gt;
&lt;br /&gt;
==[[Drug induced liver injury natural history, complications and prognosis|Natural History, Complications, and Prognosis]]==&lt;br /&gt;
&lt;br /&gt;
==Diagnosis==&lt;br /&gt;
[[Drug induced liver injury history and symptoms|History and Symptoms]] | [[Drug induced liver injury physical examination|Physical Examination]] | [[Drug induced liver injury laboratory findings|Laboratory Findings]] | [[Drug induced liver injury x ray|X Ray]] | [[Drug induced liver injury CT|CT]] | [[Drug induced liver injury MRI|MRI]] | [[Drug induced liver injury ultrasound|Ultrasound]] | [[Drug induced liver injury liver biopsy|Liver Biopsy]] | [[Drug induced liver injury other imaging findings|Other Imaging Findings]] | [[Drug induced liver injury other diagnostic studies|Other Diagnostic Studies]]&lt;br /&gt;
&lt;br /&gt;
==Treatment==&lt;br /&gt;
[[Drug induced liver injury medical therapy|Medical Therapy]] | [[Drug induced liver injury surgery|Surgery]] | [[Drug induced liver injury prevention|Prevention]] | [[Drug induced liver injury cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Drug induced liver injury future or investigational therapies|Future or Investigational Therapies]]&lt;br /&gt;
==External Links==&lt;br /&gt;
&lt;br /&gt;
{{WikiDoc Help Menu}}&lt;br /&gt;
{{WikiDoc Sources}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=User:Rachita_Navara&amp;diff=1569592</id>
		<title>User:Rachita Navara</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=User:Rachita_Navara&amp;diff=1569592"/>
		<updated>2019-05-24T04:00:05Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Professional Background */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
==Rachita Navara, M.D.==&lt;br /&gt;
[[File:Dr. Rachita Navara.jpg|thumb|311x311px|Rachita Navara, M.D. is a resident physician at Stanford University Hospital]]&lt;br /&gt;
WikiDoc Physician Contributor&lt;br /&gt;
&amp;lt;br /&amp;gt;Contact:&amp;lt;br /&amp;gt;&lt;br /&gt;
Email: [mailto:rachita@stanford.edu]&lt;br /&gt;
&lt;br /&gt;
==Current Position==&lt;br /&gt;
* Associate Editor-in-Chief, WikiDoc&lt;br /&gt;
&lt;br /&gt;
==Professional Background==&lt;br /&gt;
*&#039;&#039;&#039;Washington University in St. Louis Medical Center, Cardiology Fellowship, Class of 2021&#039;&#039;&#039;&amp;lt;br /&amp;gt;      Research in Electrophysiology and Innovation&lt;br /&gt;
*&#039;&#039;&#039;Stanford University Medical Center, Internal Medicine Residency, Class of 2018&#039;&#039;&#039;&amp;lt;br /&amp;gt;      Pathway of Distinction: Biodesign and Innovation&amp;lt;br /&amp;gt;      Stanford Society of Physician Scholars research grant recipient in Cardiology&lt;br /&gt;
&lt;br /&gt;
*&#039;&#039;&#039;University of Texas Southwestern Medical Center, M.D. Class of 2015&#039;&#039;&#039;&amp;lt;br /&amp;gt;      Concentration in Innovating Healthcare Solutions&lt;br /&gt;
&lt;br /&gt;
*&#039;&#039;&#039;Franklin W. Olin College of Engineering, B.S. in Bioengineering, Class of 2011&#039;&#039;&#039;&amp;lt;br /&amp;gt;      Recipient of full-tuition Franklin W. Olin and Robert C. Byrd scholarships&amp;lt;br /&amp;gt;      Concentrations in Creative Writing, Hindi/Urdu Language&amp;lt;br /&amp;gt;      Senior college writing tutor&lt;br /&gt;
==Brief Biography==&lt;br /&gt;
Dr. Rachita Navara began with WikiDoc as a first year resident in the Department of Medicine at Stanford University. She received her M.D. from the University of Texas Southwestern Medical Center and her B.S. in Bioengineering from the innovative Franklin W. Olin College of Engineering. She was recruited to the Washington University in St. Louis Medical Center to research novel noninvasive radioablation of arrhythmias during Cardiology Fellowship. Research interests range from biomedical device design to the physiology of arrhythmic circuits in the heart. Outside medicine, Rachita’s hobbies include watercolor painting, competitive scrabble, and singing – a tribute to her medical school band “The Pacemakers.”&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_historical_perspective&amp;diff=1268855</id>
		<title>Drug induced liver injury historical perspective</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_historical_perspective&amp;diff=1268855"/>
		<updated>2016-11-10T02:44:02Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Drug induced liver injury has been historically underreported.&lt;br /&gt;
&lt;br /&gt;
==Historical Perspective==&lt;br /&gt;
Over the last fifty years, the United States Food and Drug Administration has withdrawn several drugs from the market for causing severe liver injury. Notably in 1997 to 1998, bromfenac and troglitazone were withdrawn from the market for causing severe hepatocellular injury. Drug induced liver injury remains the most frequent single cause of drug withdrawals from the market today.&amp;lt;ref name=FDA1&amp;gt; United States Food and Drug Administration. Guidance for Industry. http://www.fda.gov/downloads/Drugs/.../Guidances/UCM174090.pdf Accessed on October 24, 2016 &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1268854</id>
		<title>Drug induced liver injury natural history, complications and prognosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1268854"/>
		<updated>2016-11-10T02:40:23Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The clinical course of drug induced liver injury varies based on causative drug.&amp;lt;ref name=&amp;quot;pmid24879979&amp;quot;&amp;gt;{{cite journal| author=Hayashi PH, Fontana RJ| title=Clinical features, diagnosis, and natural history of drug-induced liver injury. | journal=Semin Liver Dis | year= 2014 | volume= 34 | issue= 2 | pages= 134-44 | pmid=24879979 | doi=10.1055/s-0034-1375955 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24879979  }} &amp;lt;/ref&amp;gt; There is a hallmark latent period between the initiation of the drug (&amp;quot;the challenge&amp;quot;) and the development of either symptoms or, more commonly, asymptomatic elevations in serum alanine aminotransferase. Liver injury typically recurs if the drug is reintroduced in the future, often with greater severity that could be life-threatening. Prompt withdrawal of the offending drug leads to complete resolution in 90% of patients, with no long-term sequelae. &lt;br /&gt;
&lt;br /&gt;
==Natural History==&lt;br /&gt;
There is a hallmark latent period between the initiation of the drug (&amp;quot;the challenge&amp;quot;) and the development of either symptoms or, more commonly, asymptomatic elevations in serum alanine aminotransferase. Once the diagnosis of drug induced liver injury is established and the inciting drug is withdrawn, the &amp;quot;dechallenge&amp;quot; or clinical improvement is relatively immediate. Liver injury typically recurs if the drug is reintroduced in the future, often with greater severity that could be life-threatening. &lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
The main complication that can develop as a result of drug induced liver injury is chronic liver failure in 5-10% of patients, particularly if they have preexisting liver disease. Up to 10% of patients with drug induced liver injury do not survive the initial injury or require liver transplantation. Overall, complications are dependent on the inciting drug and patient risk factors. &lt;br /&gt;
&lt;br /&gt;
==Prognosis==&lt;br /&gt;
Prompt withdrawal of the offending drug leads to complete resolution in 90% of patients, with no long-term sequelae. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_causes&amp;diff=1262500</id>
		<title>Drug induced liver injury causes</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_causes&amp;diff=1262500"/>
		<updated>2016-10-19T22:15:35Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Common Causes */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Hundreds of prescription and nonprescription medications as well as supplements have been implicated in drug induced liver injury. A free searchable database of causative agents is available through the National Institute of Health: https://livertox.nlm.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Common Causative Agents:===&lt;br /&gt;
*[[Acetaminophen]]&lt;br /&gt;
*[[Azithromycin]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Tetracycline]]&lt;br /&gt;
*[[Rosiglitazone]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Valproic Acid]]&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
*[[Rifampin]]&lt;br /&gt;
&lt;br /&gt;
===Causes by Organ System===&lt;br /&gt;
{|style=&amp;quot;width:80%; height:100px&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:25%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;LightSteelBlue&amp;quot; | &#039;&#039;&#039;Cardiovascular&#039;&#039;&#039;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:75%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;Beige&amp;quot; | No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Chemical / poisoning&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Dermatologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Drug Side Effect&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| [[5-Azacytidine]], [[Abacavir]], [[Abiraterone]], [[Acetaminophen]], [[Agomelatine]], [[Albendazole]], [[Allopurinol]], [[Altretamine]], [[Amineptine]], [[Amiodarone]], [[Amitriptyline]], [[Amoxicillin]], [[Amphotericin B]], [[Amprenavir]], [[Anabolic steroids]], [[Antituberculosis drugs]], [[Apixaban]], [[Arsenic trioxide]], [[Asafetida]], [[Asparaginase]], [[Atorvastatin]], [[Atovaquone]], [[Azathioprine]], [[Benoxaprofen]], [[Bexarotene]], [[Black cohosh extract]], [[Bosentan]], [[Bosutinib]], [[Bromfenac]], [[Bumetanide]], [[Carfilzomib]], [[Cascara]], [[Caspofungin]], [[Chaparral]], [[Chenodeoxycholic acid]], [[Chlormezanone]], [[Chlorzoxazone]], [[Ciprofloxacin]], [[Clofarabine]], [[Combined oral contraceptive pill]], [[Comfrey]], [[Crizotinib]], [[Cyclobenzaprine]], [[Dantrolene]], [[Daptomycin]], [[Dasatinib]], [[Deferasirox]], [[Desipramine]], [[Diclofenac]], [[Disulfiram]], [[Docetaxel]], [[Donepezil]], [[Dothiepin]], [[Dronedarone]], [[Eltrombopag]], [[Emtricitabine]], [[Entecavir]], [[Ephedra]], [[Erlotinib]], [[Erythromycin estolate]], [[Ethanol]], [[Ethinylestradiol]], [[Ethionamide]], [[Etretinate]], [[Febuxostat]], [[Felbamate]], [[Fenofibrate]], [[Fingolimod]], [[Fluconazole]], [[Flucytosine]], [[Fluoxymesterone]], [[Flutamide]], [[Fluvastatin]], [[Fosamprenavir]], [[Frusemide]], [[Fusidic acid]], [[Ganciclovir]], [[Gemcitabine]], [[Gemtuzumab ozogamicin]], [[Gold salts]], [[Golimumab]], [[Halothane]], [[Imatinib mesylate]], [[Imipenem]], [[Interferon alpha]], [[Interferon beta]], [[Interleukin 2]], [[Ipilimumab]], [[Isoniazid]], [[Isotretinoin]], [[Kava root extract]], [[Ketoconazole]], [[Lapatinib ditosylate]], [[Leflunomide]], [[Lovastatin]], [[Maraviroc]], [[Meropenem]], [[Mesalazine]], [[Methotrexate]], [[Methyldopa]], [[Methyldopate]], [[Micafungin]], [[Minocycline]], [[Mirtazapine]], [[Mithramycin]], [[Naltrexone]], [[Nandrolone]], [[Natalizumab]], [[Nelfinavir]], [[Nevirapine]], [[Niacin]], [[Nicotinic acid]], [[Nimesulide]], [[Nitisinone]], [[Nitrofurantoin]], [[Norfloxacin]], [[Nortriptyline]], [[Ondansetron]], [[Oxyphenisatine]], [[Paclitaxel]], [[Para-amino salicylic acid]], [[Pazopanib]], [[Pegvisomant]], [[Pemoline]], [[Pentostatin]], [[Phenelzine]], [[Phenylbutazone]], [[Phenytoin]], [[Pralatrexate]], [[Pravastatin]], [[Procainamide]], [[Propylthiouracil]], [[Prothionamide]], [[Pyrazinamide]], [[Pyritinol]], [[Pyrrolizidine alkaloids]], [[Regorafenib]], [[Rifabutin]], [[Rifampicin]], [[Riluzole]], [[Ritonavir]], [[Rivaroxaban]], [[Rosuvastatin]], [[Saquinavir]], [[Simvastatin]], [[Sitaxentan]], [[Sorafenib]], [[Stanozolol]], [[Statins]], [[Succimer]], [[Suloctidil]], [[Sulphasalazine]], [[Sulphinpyrazone]], [[Tegafur]], [[Telithromycin]], [[Teriflunomide]], [[Thiabendazole]], [[Thioguanine]], [[Ticlopidine]], [[Tipranavir]], [[Tizanidine]], [[Tolbutamide]], [[Tolcapone]], [[Tolrestat]], [[Trabectedin]], [[Troglitazone]], [[Trovafloxacin]], [[Ursodeoxycholic acid]], [[Valganciclovir]], [[Valproic acid]], [[Velnacrine]], [[Verapamil]], [[Voriconazole]], [[Ximelagatran]], [[Zotepine]], [[Alcohol]], [[Carbimazole]], [[Phenothiazines]], [[Clofibrate]], [[Tetracyclines]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Ear Nose Throat&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|- &lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Endocrine&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|- &lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Environmental&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Gastroenterologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Genetic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Hematologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Iatrogenic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Infectious Disease&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Musculoskeletal / Ortho&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Neurologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Nutritional / Metabolic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Obstetric/Gynecologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Oncologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Opthalmologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Overdose / Toxicity&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Psychiatric&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Pulmonary&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Renal / Electrolyte&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Rheum / Immune / Allergy&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Sexual&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Trauma&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Urologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Dental&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Miscellaneous&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
===Causes in Alphabetical Order===&lt;br /&gt;
{{MultiCol}}&lt;br /&gt;
*[[5-Azacytidine]]&lt;br /&gt;
*[[Abacavir]]&lt;br /&gt;
*[[Abiraterone]]&lt;br /&gt;
*[[Acetaminophen]]&lt;br /&gt;
*[[Agomelatine]]&lt;br /&gt;
*[[Albendazole]]&lt;br /&gt;
*[[Alcohol]]&lt;br /&gt;
*[[Allopurinol]]&lt;br /&gt;
*[[Altretamine]]&lt;br /&gt;
*[[Amineptine]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Amitriptyline]]&lt;br /&gt;
*[[Amoxicillin]]&lt;br /&gt;
*[[Amphotericin B]]&lt;br /&gt;
*[[Amprenavir]]&lt;br /&gt;
*[[Anabolic steroids]]&lt;br /&gt;
*[[Antituberculosis drugs]]&lt;br /&gt;
*[[Apixaban]]&lt;br /&gt;
*[[Arsenic trioxide]]&lt;br /&gt;
*[[Asafetida]]&lt;br /&gt;
*[[Asparaginase]]&lt;br /&gt;
*[[Atorvastatin]]&lt;br /&gt;
*[[Atovaquone]]&lt;br /&gt;
*[[Azathioprine]]&lt;br /&gt;
*[[Benoxaprofen]]&lt;br /&gt;
*[[Bexarotene]]&lt;br /&gt;
*[[Black cohosh extract]]&lt;br /&gt;
*[[Bosentan]]&lt;br /&gt;
*[[Bosutinib]]&lt;br /&gt;
*[[Bromfenac]]&lt;br /&gt;
*[[Bumetanide]]&lt;br /&gt;
*[[Carbimazole]]&lt;br /&gt;
*[[Carfilzomib]]&lt;br /&gt;
*[[Cascara]]&lt;br /&gt;
*[[Caspofungin]]&lt;br /&gt;
*[[Chaparral]]&lt;br /&gt;
*[[Chenodeoxycholic acid]]&lt;br /&gt;
*[[Chlormezanone]]&lt;br /&gt;
*[[Chlorzoxazone]]&lt;br /&gt;
*[[Ciprofloxacin]]&lt;br /&gt;
*[[Clofarabine]]&lt;br /&gt;
*[[Clofibrate]]&lt;br /&gt;
*[[Combined oral contraceptive pill]]&lt;br /&gt;
*[[Comfrey]]&lt;br /&gt;
*[[Crizotinib]]&lt;br /&gt;
*[[Cyclobenzaprine]]&lt;br /&gt;
*[[Dantrolene]]&lt;br /&gt;
*[[Daptomycin]]&lt;br /&gt;
*[[Dasatinib]]&lt;br /&gt;
*[[Deferasirox]]&lt;br /&gt;
*[[Desipramine]]&lt;br /&gt;
*[[Diclofenac]]&lt;br /&gt;
*[[Disulfiram]]&lt;br /&gt;
*[[Docetaxel]]&lt;br /&gt;
*[[Donepezil]]&lt;br /&gt;
*[[Dothiepin]]&lt;br /&gt;
*[[Dronedarone]]&lt;br /&gt;
*[[Eltrombopag]]&lt;br /&gt;
*[[Emtricitabine]]&lt;br /&gt;
*[[Entecavir]]&lt;br /&gt;
*[[Ephedra]]&lt;br /&gt;
*[[Erlotinib]]&lt;br /&gt;
*[[Erythromycin estolate]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Ethinylestradiol]]&lt;br /&gt;
*[[Ethionamide]]&lt;br /&gt;
*[[Etretinate]]&lt;br /&gt;
*[[Febuxostat]]&lt;br /&gt;
*[[Felbamate]]&lt;br /&gt;
*[[Fenofibrate]]&lt;br /&gt;
*[[Fingolimod]]&lt;br /&gt;
*[[Fluconazole]]&lt;br /&gt;
*[[Flucytosine]]&lt;br /&gt;
*[[Fluoxymesterone]]&lt;br /&gt;
*[[Flutamide]]&lt;br /&gt;
*[[Fluvastatin]]&lt;br /&gt;
*[[Fosamprenavir]]&lt;br /&gt;
*[[Frusemide]]&lt;br /&gt;
*[[Fusidic acid]]&lt;br /&gt;
*[[Ganciclovir]]&lt;br /&gt;
*[[Gemcitabine]]&lt;br /&gt;
*[[Gemtuzumab ozogamicin]]&lt;br /&gt;
*[[Gold salts]]&lt;br /&gt;
*[[Golimumab]]&lt;br /&gt;
*[[Halothane]]&lt;br /&gt;
*[[Imatinib mesylate]]&lt;br /&gt;
*[[Imipenem]]&lt;br /&gt;
*[[Interferon alpha]]&lt;br /&gt;
*[[Interferon beta]]&lt;br /&gt;
*[[Interleukin 2]]&lt;br /&gt;
*[[Ipilimumab]]&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
{{ColBreak}}&lt;br /&gt;
*[[Isotretinoin]]&lt;br /&gt;
*[[Kava root extract]]&lt;br /&gt;
*[[Ketoconazole]]&lt;br /&gt;
*[[Lapatinib ditosylate]]&lt;br /&gt;
*[[Leflunomide]]&lt;br /&gt;
*[[Lovastatin]]&lt;br /&gt;
*[[Maraviroc]]&lt;br /&gt;
*[[Meropenem]]&lt;br /&gt;
*[[Mesalazine]]&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
*[[Methyldopa]]&lt;br /&gt;
*[[Methyldopate]]&lt;br /&gt;
*[[Micafungin]]&lt;br /&gt;
*[[Minocycline]]&lt;br /&gt;
*[[Mirtazapine]]&lt;br /&gt;
*[[Mithramycin]]&lt;br /&gt;
*[[Naltrexone]]&lt;br /&gt;
*[[Nandrolone]]&lt;br /&gt;
*[[Natalizumab]]&lt;br /&gt;
*[[Nelfinavir]]&lt;br /&gt;
*[[Nevirapine]]&lt;br /&gt;
*[[Niacin]]&lt;br /&gt;
*[[Nicotinic acid]]&lt;br /&gt;
*[[Nimesulide]]&lt;br /&gt;
*[[Nitisinone]]&lt;br /&gt;
*[[Nitrofurantoin]]&lt;br /&gt;
*[[Norfloxacin]]&lt;br /&gt;
*[[Nortriptyline]]&lt;br /&gt;
*[[Ondansetron]]&lt;br /&gt;
*[[Oxyphenisatine]]&lt;br /&gt;
*[[Paclitaxel]]&lt;br /&gt;
*[[Para-amino salicylic acid]]&lt;br /&gt;
*[[Pazopanib]]&lt;br /&gt;
*[[Pegvisomant]]&lt;br /&gt;
*[[Pemoline]]&lt;br /&gt;
*[[Pentostatin]]&lt;br /&gt;
*[[Phenelzine]]&lt;br /&gt;
*[[Phenothiazines]]&lt;br /&gt;
*[[Phenylbutazone]]&lt;br /&gt;
*[[Phenytoin]]&lt;br /&gt;
*[[Pralatrexate]]&lt;br /&gt;
*[[Pravastatin]]&lt;br /&gt;
*[[Procainamide]]&lt;br /&gt;
*[[Propylthiouracil]]&lt;br /&gt;
*[[Prothionamide]]&lt;br /&gt;
*[[Pyrazinamide]]&lt;br /&gt;
*[[Pyritinol]]&lt;br /&gt;
*[[Pyrrolizidine alkaloids]]&lt;br /&gt;
*[[Regorafenib]]&lt;br /&gt;
*[[Rifabutin]]&lt;br /&gt;
*[[Rifampicin]]&lt;br /&gt;
*[[Riluzole]]&lt;br /&gt;
*[[Ritonavir]]&lt;br /&gt;
*[[Rivaroxaban]]&lt;br /&gt;
*[[Rosuvastatin]]&lt;br /&gt;
*[[Saquinavir]]&lt;br /&gt;
*[[Simvastatin]]&lt;br /&gt;
*[[Sitaxentan]]&lt;br /&gt;
*[[Sorafenib]]&lt;br /&gt;
*[[Stanozolol]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Succimer]]&lt;br /&gt;
*[[Suloctidil]]&lt;br /&gt;
*[[Sulphasalazine]]&lt;br /&gt;
*[[Sulphinpyrazone]]&lt;br /&gt;
*[[Tegafur]]&lt;br /&gt;
*[[Telithromycin]]&lt;br /&gt;
*[[Teriflunomide]]&lt;br /&gt;
*[[Tetracyclines]]&lt;br /&gt;
*[[Thiabendazole]]&lt;br /&gt;
*[[Thioguanine]]&lt;br /&gt;
*[[Ticlopidine]]&lt;br /&gt;
*[[Tipranavir]]&lt;br /&gt;
*[[Tizanidine]]&lt;br /&gt;
*[[Tolbutamide]]&lt;br /&gt;
*[[Tolcapone]]&lt;br /&gt;
*[[Tolrestat]]&lt;br /&gt;
*[[Trabectedin]]&lt;br /&gt;
*[[Troglitazone]]&lt;br /&gt;
*[[Trovafloxacin]]&lt;br /&gt;
*[[Ursodeoxycholic acid]]&lt;br /&gt;
*[[Valganciclovir]]&lt;br /&gt;
*[[Valproic acid]]&lt;br /&gt;
*[[Velnacrine]]&lt;br /&gt;
*[[Verapamil]]&lt;br /&gt;
*[[Voriconazole]]&lt;br /&gt;
*[[Ximelagatran]]&lt;br /&gt;
*[[Zotepine]]&lt;br /&gt;
{{EndMultiCol}}&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_causes&amp;diff=1262499</id>
		<title>Drug induced liver injury causes</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_causes&amp;diff=1262499"/>
		<updated>2016-10-19T22:14:09Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Hundreds of prescription and nonprescription medications as well as supplements have been implicated in drug induced liver injury. A free searchable database of causative agents is available through the National Institute of Health: https://livertox.nlm.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Common Causes===&lt;br /&gt;
*[[Acetaminophen]]&lt;br /&gt;
*[[Azithromycin]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Tetracycline]]&lt;br /&gt;
*[[Rosiglitazone]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Valproic Acid]]&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
*[[Rifampin]]&lt;br /&gt;
&lt;br /&gt;
===Causes by Organ System===&lt;br /&gt;
{|style=&amp;quot;width:80%; height:100px&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:25%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;LightSteelBlue&amp;quot; | &#039;&#039;&#039;Cardiovascular&#039;&#039;&#039;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:75%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;Beige&amp;quot; | No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Chemical / poisoning&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Dermatologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Drug Side Effect&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| [[5-Azacytidine]], [[Abacavir]], [[Abiraterone]], [[Acetaminophen]], [[Agomelatine]], [[Albendazole]], [[Allopurinol]], [[Altretamine]], [[Amineptine]], [[Amiodarone]], [[Amitriptyline]], [[Amoxicillin]], [[Amphotericin B]], [[Amprenavir]], [[Anabolic steroids]], [[Antituberculosis drugs]], [[Apixaban]], [[Arsenic trioxide]], [[Asafetida]], [[Asparaginase]], [[Atorvastatin]], [[Atovaquone]], [[Azathioprine]], [[Benoxaprofen]], [[Bexarotene]], [[Black cohosh extract]], [[Bosentan]], [[Bosutinib]], [[Bromfenac]], [[Bumetanide]], [[Carfilzomib]], [[Cascara]], [[Caspofungin]], [[Chaparral]], [[Chenodeoxycholic acid]], [[Chlormezanone]], [[Chlorzoxazone]], [[Ciprofloxacin]], [[Clofarabine]], [[Combined oral contraceptive pill]], [[Comfrey]], [[Crizotinib]], [[Cyclobenzaprine]], [[Dantrolene]], [[Daptomycin]], [[Dasatinib]], [[Deferasirox]], [[Desipramine]], [[Diclofenac]], [[Disulfiram]], [[Docetaxel]], [[Donepezil]], [[Dothiepin]], [[Dronedarone]], [[Eltrombopag]], [[Emtricitabine]], [[Entecavir]], [[Ephedra]], [[Erlotinib]], [[Erythromycin estolate]], [[Ethanol]], [[Ethinylestradiol]], [[Ethionamide]], [[Etretinate]], [[Febuxostat]], [[Felbamate]], [[Fenofibrate]], [[Fingolimod]], [[Fluconazole]], [[Flucytosine]], [[Fluoxymesterone]], [[Flutamide]], [[Fluvastatin]], [[Fosamprenavir]], [[Frusemide]], [[Fusidic acid]], [[Ganciclovir]], [[Gemcitabine]], [[Gemtuzumab ozogamicin]], [[Gold salts]], [[Golimumab]], [[Halothane]], [[Imatinib mesylate]], [[Imipenem]], [[Interferon alpha]], [[Interferon beta]], [[Interleukin 2]], [[Ipilimumab]], [[Isoniazid]], [[Isotretinoin]], [[Kava root extract]], [[Ketoconazole]], [[Lapatinib ditosylate]], [[Leflunomide]], [[Lovastatin]], [[Maraviroc]], [[Meropenem]], [[Mesalazine]], [[Methotrexate]], [[Methyldopa]], [[Methyldopate]], [[Micafungin]], [[Minocycline]], [[Mirtazapine]], [[Mithramycin]], [[Naltrexone]], [[Nandrolone]], [[Natalizumab]], [[Nelfinavir]], [[Nevirapine]], [[Niacin]], [[Nicotinic acid]], [[Nimesulide]], [[Nitisinone]], [[Nitrofurantoin]], [[Norfloxacin]], [[Nortriptyline]], [[Ondansetron]], [[Oxyphenisatine]], [[Paclitaxel]], [[Para-amino salicylic acid]], [[Pazopanib]], [[Pegvisomant]], [[Pemoline]], [[Pentostatin]], [[Phenelzine]], [[Phenylbutazone]], [[Phenytoin]], [[Pralatrexate]], [[Pravastatin]], [[Procainamide]], [[Propylthiouracil]], [[Prothionamide]], [[Pyrazinamide]], [[Pyritinol]], [[Pyrrolizidine alkaloids]], [[Regorafenib]], [[Rifabutin]], [[Rifampicin]], [[Riluzole]], [[Ritonavir]], [[Rivaroxaban]], [[Rosuvastatin]], [[Saquinavir]], [[Simvastatin]], [[Sitaxentan]], [[Sorafenib]], [[Stanozolol]], [[Statins]], [[Succimer]], [[Suloctidil]], [[Sulphasalazine]], [[Sulphinpyrazone]], [[Tegafur]], [[Telithromycin]], [[Teriflunomide]], [[Thiabendazole]], [[Thioguanine]], [[Ticlopidine]], [[Tipranavir]], [[Tizanidine]], [[Tolbutamide]], [[Tolcapone]], [[Tolrestat]], [[Trabectedin]], [[Troglitazone]], [[Trovafloxacin]], [[Ursodeoxycholic acid]], [[Valganciclovir]], [[Valproic acid]], [[Velnacrine]], [[Verapamil]], [[Voriconazole]], [[Ximelagatran]], [[Zotepine]], [[Alcohol]], [[Carbimazole]], [[Phenothiazines]], [[Clofibrate]], [[Tetracyclines]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Ear Nose Throat&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|- &lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Endocrine&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|- &lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Environmental&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Gastroenterologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Genetic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Hematologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Iatrogenic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Infectious Disease&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Musculoskeletal / Ortho&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Neurologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Nutritional / Metabolic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Obstetric/Gynecologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Oncologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Opthalmologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Overdose / Toxicity&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Psychiatric&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Pulmonary&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Renal / Electrolyte&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Rheum / Immune / Allergy&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Sexual&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Trauma&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Urologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Dental&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Miscellaneous&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
===Causes in Alphabetical Order===&lt;br /&gt;
{{MultiCol}}&lt;br /&gt;
*[[5-Azacytidine]]&lt;br /&gt;
*[[Abacavir]]&lt;br /&gt;
*[[Abiraterone]]&lt;br /&gt;
*[[Acetaminophen]]&lt;br /&gt;
*[[Agomelatine]]&lt;br /&gt;
*[[Albendazole]]&lt;br /&gt;
*[[Alcohol]]&lt;br /&gt;
*[[Allopurinol]]&lt;br /&gt;
*[[Altretamine]]&lt;br /&gt;
*[[Amineptine]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Amitriptyline]]&lt;br /&gt;
*[[Amoxicillin]]&lt;br /&gt;
*[[Amphotericin B]]&lt;br /&gt;
*[[Amprenavir]]&lt;br /&gt;
*[[Anabolic steroids]]&lt;br /&gt;
*[[Antituberculosis drugs]]&lt;br /&gt;
*[[Apixaban]]&lt;br /&gt;
*[[Arsenic trioxide]]&lt;br /&gt;
*[[Asafetida]]&lt;br /&gt;
*[[Asparaginase]]&lt;br /&gt;
*[[Atorvastatin]]&lt;br /&gt;
*[[Atovaquone]]&lt;br /&gt;
*[[Azathioprine]]&lt;br /&gt;
*[[Benoxaprofen]]&lt;br /&gt;
*[[Bexarotene]]&lt;br /&gt;
*[[Black cohosh extract]]&lt;br /&gt;
*[[Bosentan]]&lt;br /&gt;
*[[Bosutinib]]&lt;br /&gt;
*[[Bromfenac]]&lt;br /&gt;
*[[Bumetanide]]&lt;br /&gt;
*[[Carbimazole]]&lt;br /&gt;
*[[Carfilzomib]]&lt;br /&gt;
*[[Cascara]]&lt;br /&gt;
*[[Caspofungin]]&lt;br /&gt;
*[[Chaparral]]&lt;br /&gt;
*[[Chenodeoxycholic acid]]&lt;br /&gt;
*[[Chlormezanone]]&lt;br /&gt;
*[[Chlorzoxazone]]&lt;br /&gt;
*[[Ciprofloxacin]]&lt;br /&gt;
*[[Clofarabine]]&lt;br /&gt;
*[[Clofibrate]]&lt;br /&gt;
*[[Combined oral contraceptive pill]]&lt;br /&gt;
*[[Comfrey]]&lt;br /&gt;
*[[Crizotinib]]&lt;br /&gt;
*[[Cyclobenzaprine]]&lt;br /&gt;
*[[Dantrolene]]&lt;br /&gt;
*[[Daptomycin]]&lt;br /&gt;
*[[Dasatinib]]&lt;br /&gt;
*[[Deferasirox]]&lt;br /&gt;
*[[Desipramine]]&lt;br /&gt;
*[[Diclofenac]]&lt;br /&gt;
*[[Disulfiram]]&lt;br /&gt;
*[[Docetaxel]]&lt;br /&gt;
*[[Donepezil]]&lt;br /&gt;
*[[Dothiepin]]&lt;br /&gt;
*[[Dronedarone]]&lt;br /&gt;
*[[Eltrombopag]]&lt;br /&gt;
*[[Emtricitabine]]&lt;br /&gt;
*[[Entecavir]]&lt;br /&gt;
*[[Ephedra]]&lt;br /&gt;
*[[Erlotinib]]&lt;br /&gt;
*[[Erythromycin estolate]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Ethinylestradiol]]&lt;br /&gt;
*[[Ethionamide]]&lt;br /&gt;
*[[Etretinate]]&lt;br /&gt;
*[[Febuxostat]]&lt;br /&gt;
*[[Felbamate]]&lt;br /&gt;
*[[Fenofibrate]]&lt;br /&gt;
*[[Fingolimod]]&lt;br /&gt;
*[[Fluconazole]]&lt;br /&gt;
*[[Flucytosine]]&lt;br /&gt;
*[[Fluoxymesterone]]&lt;br /&gt;
*[[Flutamide]]&lt;br /&gt;
*[[Fluvastatin]]&lt;br /&gt;
*[[Fosamprenavir]]&lt;br /&gt;
*[[Frusemide]]&lt;br /&gt;
*[[Fusidic acid]]&lt;br /&gt;
*[[Ganciclovir]]&lt;br /&gt;
*[[Gemcitabine]]&lt;br /&gt;
*[[Gemtuzumab ozogamicin]]&lt;br /&gt;
*[[Gold salts]]&lt;br /&gt;
*[[Golimumab]]&lt;br /&gt;
*[[Halothane]]&lt;br /&gt;
*[[Imatinib mesylate]]&lt;br /&gt;
*[[Imipenem]]&lt;br /&gt;
*[[Interferon alpha]]&lt;br /&gt;
*[[Interferon beta]]&lt;br /&gt;
*[[Interleukin 2]]&lt;br /&gt;
*[[Ipilimumab]]&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
{{ColBreak}}&lt;br /&gt;
*[[Isotretinoin]]&lt;br /&gt;
*[[Kava root extract]]&lt;br /&gt;
*[[Ketoconazole]]&lt;br /&gt;
*[[Lapatinib ditosylate]]&lt;br /&gt;
*[[Leflunomide]]&lt;br /&gt;
*[[Lovastatin]]&lt;br /&gt;
*[[Maraviroc]]&lt;br /&gt;
*[[Meropenem]]&lt;br /&gt;
*[[Mesalazine]]&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
*[[Methyldopa]]&lt;br /&gt;
*[[Methyldopate]]&lt;br /&gt;
*[[Micafungin]]&lt;br /&gt;
*[[Minocycline]]&lt;br /&gt;
*[[Mirtazapine]]&lt;br /&gt;
*[[Mithramycin]]&lt;br /&gt;
*[[Naltrexone]]&lt;br /&gt;
*[[Nandrolone]]&lt;br /&gt;
*[[Natalizumab]]&lt;br /&gt;
*[[Nelfinavir]]&lt;br /&gt;
*[[Nevirapine]]&lt;br /&gt;
*[[Niacin]]&lt;br /&gt;
*[[Nicotinic acid]]&lt;br /&gt;
*[[Nimesulide]]&lt;br /&gt;
*[[Nitisinone]]&lt;br /&gt;
*[[Nitrofurantoin]]&lt;br /&gt;
*[[Norfloxacin]]&lt;br /&gt;
*[[Nortriptyline]]&lt;br /&gt;
*[[Ondansetron]]&lt;br /&gt;
*[[Oxyphenisatine]]&lt;br /&gt;
*[[Paclitaxel]]&lt;br /&gt;
*[[Para-amino salicylic acid]]&lt;br /&gt;
*[[Pazopanib]]&lt;br /&gt;
*[[Pegvisomant]]&lt;br /&gt;
*[[Pemoline]]&lt;br /&gt;
*[[Pentostatin]]&lt;br /&gt;
*[[Phenelzine]]&lt;br /&gt;
*[[Phenothiazines]]&lt;br /&gt;
*[[Phenylbutazone]]&lt;br /&gt;
*[[Phenytoin]]&lt;br /&gt;
*[[Pralatrexate]]&lt;br /&gt;
*[[Pravastatin]]&lt;br /&gt;
*[[Procainamide]]&lt;br /&gt;
*[[Propylthiouracil]]&lt;br /&gt;
*[[Prothionamide]]&lt;br /&gt;
*[[Pyrazinamide]]&lt;br /&gt;
*[[Pyritinol]]&lt;br /&gt;
*[[Pyrrolizidine alkaloids]]&lt;br /&gt;
*[[Regorafenib]]&lt;br /&gt;
*[[Rifabutin]]&lt;br /&gt;
*[[Rifampicin]]&lt;br /&gt;
*[[Riluzole]]&lt;br /&gt;
*[[Ritonavir]]&lt;br /&gt;
*[[Rivaroxaban]]&lt;br /&gt;
*[[Rosuvastatin]]&lt;br /&gt;
*[[Saquinavir]]&lt;br /&gt;
*[[Simvastatin]]&lt;br /&gt;
*[[Sitaxentan]]&lt;br /&gt;
*[[Sorafenib]]&lt;br /&gt;
*[[Stanozolol]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Succimer]]&lt;br /&gt;
*[[Suloctidil]]&lt;br /&gt;
*[[Sulphasalazine]]&lt;br /&gt;
*[[Sulphinpyrazone]]&lt;br /&gt;
*[[Tegafur]]&lt;br /&gt;
*[[Telithromycin]]&lt;br /&gt;
*[[Teriflunomide]]&lt;br /&gt;
*[[Tetracyclines]]&lt;br /&gt;
*[[Thiabendazole]]&lt;br /&gt;
*[[Thioguanine]]&lt;br /&gt;
*[[Ticlopidine]]&lt;br /&gt;
*[[Tipranavir]]&lt;br /&gt;
*[[Tizanidine]]&lt;br /&gt;
*[[Tolbutamide]]&lt;br /&gt;
*[[Tolcapone]]&lt;br /&gt;
*[[Tolrestat]]&lt;br /&gt;
*[[Trabectedin]]&lt;br /&gt;
*[[Troglitazone]]&lt;br /&gt;
*[[Trovafloxacin]]&lt;br /&gt;
*[[Ursodeoxycholic acid]]&lt;br /&gt;
*[[Valganciclovir]]&lt;br /&gt;
*[[Valproic acid]]&lt;br /&gt;
*[[Velnacrine]]&lt;br /&gt;
*[[Verapamil]]&lt;br /&gt;
*[[Voriconazole]]&lt;br /&gt;
*[[Ximelagatran]]&lt;br /&gt;
*[[Zotepine]]&lt;br /&gt;
{{EndMultiCol}}&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_causes&amp;diff=1262498</id>
		<title>Drug induced liver injury causes</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_causes&amp;diff=1262498"/>
		<updated>2016-10-19T22:13:06Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Hundreds of prescription and nonprescription medications as well as supplements have been implicated in drug induced liver injury. A free searchable database of causative agents is available through the National Institute of Health: https://livertox.nlm.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
==Causes==&lt;br /&gt;
===Common Causes===&lt;br /&gt;
*[[Acetaminophen]]&lt;br /&gt;
*[[Azithromycin]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Tetracycline]]&lt;br /&gt;
*[[Rosiglitazone]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Valproic Acid]]&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
*[[Rifampin]]&lt;br /&gt;
&lt;br /&gt;
===Causes by Organ System===&lt;br /&gt;
{|style=&amp;quot;width:80%; height:100px&amp;quot; border=&amp;quot;1&amp;quot;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:25%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;LightSteelBlue&amp;quot; | &#039;&#039;&#039;Cardiovascular&#039;&#039;&#039;&lt;br /&gt;
|style=&amp;quot;height:100px&amp;quot;; style=&amp;quot;width:75%&amp;quot; border=&amp;quot;1&amp;quot; bgcolor=&amp;quot;Beige&amp;quot; | No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Chemical / poisoning&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Dermatologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Drug Side Effect&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| [[5-Azacytidine]], [[Abacavir]], [[Abiraterone]], [[Acetaminophen]], [[Agomelatine]], [[Albendazole]], [[Allopurinol]], [[Altretamine]], [[Amineptine]], [[Amiodarone]], [[Amitriptyline]], [[Amoxicillin]], [[Amphotericin B]], [[Amprenavir]], [[Anabolic steroids]], [[Antituberculosis drugs]], [[Apixaban]], [[Arsenic trioxide]], [[Asafetida]], [[Asparaginase]], [[Atorvastatin]], [[Atovaquone]], [[Azathioprine]], [[Benoxaprofen]], [[Bexarotene]], [[Black cohosh extract]], [[Bosentan]], [[Bosutinib]], [[Bromfenac]], [[Bumetanide]], [[Carfilzomib]], [[Cascara]], [[Caspofungin]], [[Chaparral]], [[Chenodeoxycholic acid]], [[Chlormezanone]], [[Chlorzoxazone]], [[Ciprofloxacin]], [[Clofarabine]], [[Combined oral contraceptive pill]], [[Comfrey]], [[Crizotinib]], [[Cyclobenzaprine]], [[Dantrolene]], [[Daptomycin]], [[Dasatinib]], [[Deferasirox]], [[Desipramine]], [[Diclofenac]], [[Disulfiram]], [[Docetaxel]], [[Donepezil]], [[Dothiepin]], [[Dronedarone]], [[Eltrombopag]], [[Emtricitabine]], [[Entecavir]], [[Ephedra]], [[Erlotinib]], [[Erythromycin estolate]], [[Ethanol]], [[Ethinylestradiol]], [[Ethionamide]], [[Etretinate]], [[Febuxostat]], [[Felbamate]], [[Fenofibrate]], [[Fingolimod]], [[Fluconazole]], [[Flucytosine]], [[Fluoxymesterone]], [[Flutamide]], [[Fluvastatin]], [[Fosamprenavir]], [[Frusemide]], [[Fusidic acid]], [[Ganciclovir]], [[Gemcitabine]], [[Gemtuzumab ozogamicin]], [[Gold salts]], [[Golimumab]], [[Halothane]], [[Imatinib mesylate]], [[Imipenem]], [[Interferon alpha]], [[Interferon beta]], [[Interleukin 2]], [[Ipilimumab]], [[Isoniazid]], [[Isotretinoin]], [[Kava root extract]], [[Ketoconazole]], [[Lapatinib ditosylate]], [[Leflunomide]], [[Lovastatin]], [[Maraviroc]], [[Meropenem]], [[Mesalazine]], [[Methotrexate]], [[Methyldopa]], [[Methyldopate]], [[Micafungin]], [[Minocycline]], [[Mirtazapine]], [[Mithramycin]], [[Naltrexone]], [[Nandrolone]], [[Natalizumab]], [[Nelfinavir]], [[Nevirapine]], [[Niacin]], [[Nicotinic acid]], [[Nimesulide]], [[Nitisinone]], [[Nitrofurantoin]], [[Norfloxacin]], [[Nortriptyline]], [[Ondansetron]], [[Oxyphenisatine]], [[Paclitaxel]], [[Para-amino salicylic acid]], [[Pazopanib]], [[Pegvisomant]], [[Pemoline]], [[Pentostatin]], [[Phenelzine]], [[Phenylbutazone]], [[Phenytoin]], [[Pralatrexate]], [[Pravastatin]], [[Procainamide]], [[Propylthiouracil]], [[Prothionamide]], [[Pyrazinamide]], [[Pyritinol]], [[Pyrrolizidine alkaloids]], [[Regorafenib]], [[Rifabutin]], [[Rifampicin]], [[Riluzole]], [[Ritonavir]], [[Rivaroxaban]], [[Rosuvastatin]], [[Saquinavir]], [[Simvastatin]], [[Sitaxentan]], [[Sorafenib]], [[Stanozolol]], [[Statins]], [[Succimer]], [[Suloctidil]], [[Sulphasalazine]], [[Sulphinpyrazone]], [[Tegafur]], [[Telithromycin]], [[Teriflunomide]], [[Thiabendazole]], [[Thioguanine]], [[Ticlopidine]], [[Tipranavir]], [[Tizanidine]], [[Tolbutamide]], [[Tolcapone]], [[Tolrestat]], [[Trabectedin]], [[Troglitazone]], [[Trovafloxacin]], [[Ursodeoxycholic acid]], [[Valganciclovir]], [[Valproic acid]], [[Velnacrine]], [[Verapamil]], [[Voriconazole]], [[Ximelagatran]], [[Zotepine]], [[Alcohol]], [[Carbimazole]], [[Phenothiazines]], [[Clofibrate]], [[Tetracyclines]]&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Ear Nose Throat&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|- &lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Endocrine&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|- &lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Environmental&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Gastroenterologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Genetic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Hematologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Iatrogenic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Infectious Disease&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Musculoskeletal / Ortho&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Neurologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Nutritional / Metabolic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Obstetric/Gynecologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Oncologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Opthalmologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Overdose / Toxicity&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Psychiatric&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Pulmonary&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Renal / Electrolyte&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Rheum / Immune / Allergy&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Sexual&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Trauma&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Urologic&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Dental&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|-bgcolor=&amp;quot;LightSteelBlue&amp;quot;&lt;br /&gt;
| &#039;&#039;&#039;Miscellaneous&#039;&#039;&#039;&lt;br /&gt;
|bgcolor=&amp;quot;Beige&amp;quot;| No underlying causes&lt;br /&gt;
|-&lt;br /&gt;
|}&lt;br /&gt;
===Causes in Alphabetical Order===&lt;br /&gt;
{{MultiCol}}&lt;br /&gt;
*[[5-Azacytidine]]&lt;br /&gt;
*[[Abacavir]]&lt;br /&gt;
*[[Abiraterone]]&lt;br /&gt;
*[[Acetaminophen]]&lt;br /&gt;
*[[Agomelatine]]&lt;br /&gt;
*[[Albendazole]]&lt;br /&gt;
*[[Alcohol]]&lt;br /&gt;
*[[Allopurinol]]&lt;br /&gt;
*[[Altretamine]]&lt;br /&gt;
*[[Amineptine]]&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Amitriptyline]]&lt;br /&gt;
*[[Amoxicillin]]&lt;br /&gt;
*[[Amphotericin B]]&lt;br /&gt;
*[[Amprenavir]]&lt;br /&gt;
*[[Anabolic steroids]]&lt;br /&gt;
*[[Antituberculosis drugs]]&lt;br /&gt;
*[[Apixaban]]&lt;br /&gt;
*[[Arsenic trioxide]]&lt;br /&gt;
*[[Asafetida]]&lt;br /&gt;
*[[Asparaginase]]&lt;br /&gt;
*[[Atorvastatin]]&lt;br /&gt;
*[[Atovaquone]]&lt;br /&gt;
*[[Azathioprine]]&lt;br /&gt;
*[[Benoxaprofen]]&lt;br /&gt;
*[[Bexarotene]]&lt;br /&gt;
*[[Black cohosh extract]]&lt;br /&gt;
*[[Bosentan]]&lt;br /&gt;
*[[Bosutinib]]&lt;br /&gt;
*[[Bromfenac]]&lt;br /&gt;
*[[Bumetanide]]&lt;br /&gt;
*[[Carbimazole]]&lt;br /&gt;
*[[Carfilzomib]]&lt;br /&gt;
*[[Cascara]]&lt;br /&gt;
*[[Caspofungin]]&lt;br /&gt;
*[[Chaparral]]&lt;br /&gt;
*[[Chenodeoxycholic acid]]&lt;br /&gt;
*[[Chlormezanone]]&lt;br /&gt;
*[[Chlorzoxazone]]&lt;br /&gt;
*[[Ciprofloxacin]]&lt;br /&gt;
*[[Clofarabine]]&lt;br /&gt;
*[[Clofibrate]]&lt;br /&gt;
*[[Combined oral contraceptive pill]]&lt;br /&gt;
*[[Comfrey]]&lt;br /&gt;
*[[Crizotinib]]&lt;br /&gt;
*[[Cyclobenzaprine]]&lt;br /&gt;
*[[Dantrolene]]&lt;br /&gt;
*[[Daptomycin]]&lt;br /&gt;
*[[Dasatinib]]&lt;br /&gt;
*[[Deferasirox]]&lt;br /&gt;
*[[Desipramine]]&lt;br /&gt;
*[[Diclofenac]]&lt;br /&gt;
*[[Disulfiram]]&lt;br /&gt;
*[[Docetaxel]]&lt;br /&gt;
*[[Donepezil]]&lt;br /&gt;
*[[Dothiepin]]&lt;br /&gt;
*[[Dronedarone]]&lt;br /&gt;
*[[Eltrombopag]]&lt;br /&gt;
*[[Emtricitabine]]&lt;br /&gt;
*[[Entecavir]]&lt;br /&gt;
*[[Ephedra]]&lt;br /&gt;
*[[Erlotinib]]&lt;br /&gt;
*[[Erythromycin estolate]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Ethinylestradiol]]&lt;br /&gt;
*[[Ethionamide]]&lt;br /&gt;
*[[Etretinate]]&lt;br /&gt;
*[[Febuxostat]]&lt;br /&gt;
*[[Felbamate]]&lt;br /&gt;
*[[Fenofibrate]]&lt;br /&gt;
*[[Fingolimod]]&lt;br /&gt;
*[[Fluconazole]]&lt;br /&gt;
*[[Flucytosine]]&lt;br /&gt;
*[[Fluoxymesterone]]&lt;br /&gt;
*[[Flutamide]]&lt;br /&gt;
*[[Fluvastatin]]&lt;br /&gt;
*[[Fosamprenavir]]&lt;br /&gt;
*[[Frusemide]]&lt;br /&gt;
*[[Fusidic acid]]&lt;br /&gt;
*[[Ganciclovir]]&lt;br /&gt;
*[[Gemcitabine]]&lt;br /&gt;
*[[Gemtuzumab ozogamicin]]&lt;br /&gt;
*[[Gold salts]]&lt;br /&gt;
*[[Golimumab]]&lt;br /&gt;
*[[Halothane]]&lt;br /&gt;
*[[Imatinib mesylate]]&lt;br /&gt;
*[[Imipenem]]&lt;br /&gt;
*[[Interferon alpha]]&lt;br /&gt;
*[[Interferon beta]]&lt;br /&gt;
*[[Interleukin 2]]&lt;br /&gt;
*[[Ipilimumab]]&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
{{ColBreak}}&lt;br /&gt;
*[[Isotretinoin]]&lt;br /&gt;
*[[Kava root extract]]&lt;br /&gt;
*[[Ketoconazole]]&lt;br /&gt;
*[[Lapatinib ditosylate]]&lt;br /&gt;
*[[Leflunomide]]&lt;br /&gt;
*[[Lovastatin]]&lt;br /&gt;
*[[Maraviroc]]&lt;br /&gt;
*[[Meropenem]]&lt;br /&gt;
*[[Mesalazine]]&lt;br /&gt;
*[[Methotrexate]]&lt;br /&gt;
*[[Methyldopa]]&lt;br /&gt;
*[[Methyldopate]]&lt;br /&gt;
*[[Micafungin]]&lt;br /&gt;
*[[Minocycline]]&lt;br /&gt;
*[[Mirtazapine]]&lt;br /&gt;
*[[Mithramycin]]&lt;br /&gt;
*[[Naltrexone]]&lt;br /&gt;
*[[Nandrolone]]&lt;br /&gt;
*[[Natalizumab]]&lt;br /&gt;
*[[Nelfinavir]]&lt;br /&gt;
*[[Nevirapine]]&lt;br /&gt;
*[[Niacin]]&lt;br /&gt;
*[[Nicotinic acid]]&lt;br /&gt;
*[[Nimesulide]]&lt;br /&gt;
*[[Nitisinone]]&lt;br /&gt;
*[[Nitrofurantoin]]&lt;br /&gt;
*[[Norfloxacin]]&lt;br /&gt;
*[[Nortriptyline]]&lt;br /&gt;
*[[Ondansetron]]&lt;br /&gt;
*[[Oxyphenisatine]]&lt;br /&gt;
*[[Paclitaxel]]&lt;br /&gt;
*[[Para-amino salicylic acid]]&lt;br /&gt;
*[[Pazopanib]]&lt;br /&gt;
*[[Pegvisomant]]&lt;br /&gt;
*[[Pemoline]]&lt;br /&gt;
*[[Pentostatin]]&lt;br /&gt;
*[[Phenelzine]]&lt;br /&gt;
*[[Phenothiazines]]&lt;br /&gt;
*[[Phenylbutazone]]&lt;br /&gt;
*[[Phenytoin]]&lt;br /&gt;
*[[Pralatrexate]]&lt;br /&gt;
*[[Pravastatin]]&lt;br /&gt;
*[[Procainamide]]&lt;br /&gt;
*[[Propylthiouracil]]&lt;br /&gt;
*[[Prothionamide]]&lt;br /&gt;
*[[Pyrazinamide]]&lt;br /&gt;
*[[Pyritinol]]&lt;br /&gt;
*[[Pyrrolizidine alkaloids]]&lt;br /&gt;
*[[Regorafenib]]&lt;br /&gt;
*[[Rifabutin]]&lt;br /&gt;
*[[Rifampicin]]&lt;br /&gt;
*[[Riluzole]]&lt;br /&gt;
*[[Ritonavir]]&lt;br /&gt;
*[[Rivaroxaban]]&lt;br /&gt;
*[[Rosuvastatin]]&lt;br /&gt;
*[[Saquinavir]]&lt;br /&gt;
*[[Simvastatin]]&lt;br /&gt;
*[[Sitaxentan]]&lt;br /&gt;
*[[Sorafenib]]&lt;br /&gt;
*[[Stanozolol]]&lt;br /&gt;
*[[Statins]]&lt;br /&gt;
*[[Succimer]]&lt;br /&gt;
*[[Suloctidil]]&lt;br /&gt;
*[[Sulphasalazine]]&lt;br /&gt;
*[[Sulphinpyrazone]]&lt;br /&gt;
*[[Tegafur]]&lt;br /&gt;
*[[Telithromycin]]&lt;br /&gt;
*[[Teriflunomide]]&lt;br /&gt;
*[[Tetracyclines]]&lt;br /&gt;
*[[Thiabendazole]]&lt;br /&gt;
*[[Thioguanine]]&lt;br /&gt;
*[[Ticlopidine]]&lt;br /&gt;
*[[Tipranavir]]&lt;br /&gt;
*[[Tizanidine]]&lt;br /&gt;
*[[Tolbutamide]]&lt;br /&gt;
*[[Tolcapone]]&lt;br /&gt;
*[[Tolrestat]]&lt;br /&gt;
*[[Trabectedin]]&lt;br /&gt;
*[[Troglitazone]]&lt;br /&gt;
*[[Trovafloxacin]]&lt;br /&gt;
*[[Ursodeoxycholic acid]]&lt;br /&gt;
*[[Valganciclovir]]&lt;br /&gt;
*[[Valproic acid]]&lt;br /&gt;
*[[Velnacrine]]&lt;br /&gt;
*[[Verapamil]]&lt;br /&gt;
*[[Voriconazole]]&lt;br /&gt;
*[[Ximelagatran]]&lt;br /&gt;
*[[Zotepine]]&lt;br /&gt;
{{EndMultiCol}}&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_pathophysiology&amp;diff=1262495</id>
		<title>Drug induced liver injury pathophysiology</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_pathophysiology&amp;diff=1262495"/>
		<updated>2016-10-19T22:08:33Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The exact pathogenesis of drug induced liver injury is not fully understood. Possible mechanisms include both hepatocellular and extracellular processes as detailed below. &lt;br /&gt;
&lt;br /&gt;
==Genetics==&lt;br /&gt;
No specific genes have been implicated in the pathogenesis of drug induced liver injury. &lt;br /&gt;
&lt;br /&gt;
==Pathogenesis==&lt;br /&gt;
The following are possible mechanisms for drug induced liver injury that have been described in the literature:&lt;br /&gt;
&lt;br /&gt;
*Apoptosis of hepatocytes: Activation of the apoptotic pathways by the tumor necrosis factor-alpha receptor of Fas may trigger the cascade of intercellular caspases, which results in programmed cell death.&lt;br /&gt;
&lt;br /&gt;
*Bile duct injury: Toxic metabolites excreted in bile may cause injury to the bile duct epithelium.&lt;br /&gt;
&lt;br /&gt;
*Cytolytic T-cell activation: Covalent binding of a drug to the P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; enzyme acts as an immunogen, activating T cells and cytokines and stimulating a multifaceted immune response.&lt;br /&gt;
&lt;br /&gt;
*Disruption of the hepatocyte: Covalent binding of the drug to intracellular proteins can cause a decrease in ATP levels, leading to actin disruption. Disassembly of actin fibrils at the surface of the hepatocyte causes blebs and rupture of the membrane.&lt;br /&gt;
&lt;br /&gt;
*Disruption of the transport proteins: Drugs that affect transport proteins at the canalicular membrane can interrupt bile flow. Loss of villous processes and interruption of transport pumps such as multidrug resistance–associated protein 3 prevent the excretion of bilirubin, causing cholestasis.&lt;br /&gt;
&lt;br /&gt;
*Mitochondrial disruption: Certain drugs inhibit mitochondrial function by a dual effect on both beta-oxidation energy production by inhibiting the synthesis of nicotinamide adenine dinucleotide and flavin adenine dinucleotide, resulting in decreased ATP production.&lt;br /&gt;
&lt;br /&gt;
The classic division of drug reactions is into at least 2 major groups:&lt;br /&gt;
&lt;br /&gt;
# Drugs that directly affect the liver &lt;br /&gt;
# Drugs that mediate an immune response.&lt;br /&gt;
&lt;br /&gt;
Drug Toxicity Mechanisms&lt;br /&gt;
*Hypersensitivity: [[Phenytoin]] is a classic, if not common, cause of hypersensitivity reactions. The response is characterized by fever, rash, and eosinophilia and is an immune-related response with a typical short latency period of 1-4 weeks.&lt;br /&gt;
&lt;br /&gt;
*Idiosyncratic Drug Reactions: Idiosyncratic drug reactions can be subdivided into those that are classified as hypersensitivity or immunoallergic and those that are metabolic-idiosyncratic.&lt;br /&gt;
&lt;br /&gt;
*Intrinsic or predictable drug reactions: Drugs that fall into this category cause reproducible injuries in animals, and the injury is dose related. The *injury can be due to the drug itself or to a metabolite. Acetaminophen is a classic example of a known intrinsic or predictable hepatotoxin at supertherapeutic doses. Another classic example is carbon tetrachloride.&lt;br /&gt;
&lt;br /&gt;
*Metabolic-idiosyncratic: This type of reaction occurs through an indirect metabolite of the offending drug. Unlike intrinsic hepatotoxins, the response rate is variable and can occur within a week or up to one year later. It occurs in a minority of patients taking the drug, and no clinical manifestations of hypersensitivity are noted. [[INH]] toxicity is considered to fall into this class. Not all drugs fall neatly into one of these categories, and overlapping mechanisms may occur with some drugs (e.g., [[halothane]]).&lt;br /&gt;
&lt;br /&gt;
=== Drug Metabolism in Liver ===&lt;br /&gt;
[[Image:Hepatic drug metabolism.png|thumb|left|Drug metabolism in liver: transferases are : glutathione, sulfate, acetate, glucoronic acid. P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; is cytochrome P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; enzymes. 3 different pathways are depicted for Drugs A, B and C.]]&lt;br /&gt;
The human body identifies almost all drugs as foreign substances (i.e. [[xenobiotics]]) and subjects them to various chemical processes (i.e. [[metabolism]]) to make them suitable for elimination. This involves chemical transformations to (a) reduce fat solubility and (b) to change biological activity. Although almost all tissue in the body have some ability to metabolize chemicals, [[smooth endoplasmic reticulum]] in liver is the principal &amp;quot;metabolic  clearing house&amp;quot; for both [[endogenous]] chemicals (e.g., [[cholesterol]], steroid hormones,  [[fatty acids]], and [[proteins]]), and [[exogenous]] substances (e.g. drugs).&amp;lt;ref&amp;gt;{{cite book |author=Donald Blumenthal; Laurence Brunton; Keith Parker; Lazo, John S.; Iain Buxton |title=Goodman and Gilman&#039;s Pharmacological Basis of Therapeutics Digital Edition |publisher=McGraw-Hill Professional |location= |year= |pages= |isbn=0-07-146804-8 |oclc= |doi=}}&amp;lt;/ref&amp;gt; The central role played by liver in the clearance and transformation of chemicals also makes it susceptible to drug induced injury. &lt;br /&gt;
&lt;br /&gt;
[[Drug metabolism]] is usually divided into two phases: &#039;&#039;phase 1&#039;&#039; and &#039;&#039;phase 2&#039;&#039;. Phase 1 reaction is thought to prepare a drug for phase 2. However many compounds can be metabolised by phase 2 directly. Phase 1 reaction involves [[oxidation]], [[Reduction (chemistry)|reduction]], [[hydrolysis]], [[hydration]] and many other rare chemical reactions. These processes tend to increase water solubility of the drug and can generate metabolites which are more chemically active and potentially toxic. Most of phase 2 reactions take place in [[cytosol]] and involve conjugation with endogenous compounds via [[transferase]] enzymes. Chemically active phase 1 products are rendered relatively inert and suitable for elimination by this step.&lt;br /&gt;
&lt;br /&gt;
A group of [[enzyme]]s located in the endoplasmic reticulum, known as [[cytochrome P-450]], is the most important family of metabolizing enzymes in the liver. Cytochrome P-450 is the terminal [[oxidase]] component of an [[electron transport chain]]. It is not a single enzyme, rather consists of a family of closely related 50 [[isoform]]s, six of them metabolize 90% of drugs.&amp;lt;ref name=&amp;quot;isbn0-7487-6011-3&amp;quot;&amp;gt;{{cite book |author=Skett, Paul; Gibson, G. Gordon |title=Introduction to drug metabolism |publisher=Nelson Thornes Publishers |location=Cheltenham, UK |year=2001 |pages= |isbn=0-7487-6011-3 |oclc= |doi=}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid17708140&amp;quot;&amp;gt;{{cite journal |author=Lynch T, Price A |title=The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects |journal=American family physician |volume=76 |issue=3 |pages=391–6 |year=2007 |pmid=17708140 |doi=}}&amp;lt;/ref&amp;gt; There is a tremendous diversity of individual P-450 gene products and this heterogeneity allows the liver to perform oxidation on a vast array of chemicals (including almost all drugs) in phase 1. Three important characteristics of the P450 system have roles in drug induced toxicity:&lt;br /&gt;
&lt;br /&gt;
1. Genetic diversity: Each of the P-450 proteins is unique and accounts to some extent for the variation in drug metabolism between individuals. Genetic variations ([[polymorphism]]) in CYP450 metabolism should be considered when patients exhibit unusual sensitivity or resistance to drug effects at normal doses. Such polymorphism is also responsible for variable drug response among patients of differing ethnic backgrounds.&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;padding:0.3em; float:right; margin-left:5px; border:1px solid #A3B1BF;background:#F0FFFF;&amp;quot;&lt;br /&gt;
|+ &#039;&#039;Cytochrome P-450 enzyme induction and inhibition&amp;lt;ref name=&amp;quot;pmid17708140&amp;quot;/&amp;gt;&amp;lt;ref name=&amp;quot;isbn1-58562-111-0&amp;quot;&amp;gt;{{cite book |author=Jessica R. Oesterheld; Kelly L. Cozza; Armstrong, Scott |title=Concise Guide to Drug Interaction Principles for Medical Practice: Cytochrome P450s, Ugts, P-Glycoproteins |publisher=American Psychiatric Association |location=Washington, DC |year= |pages=167-396 |isbn=1-58562-111-0 |oclc= |doi=}}&amp;lt;/ref&amp;gt;&amp;lt;ref&amp;gt;Flockhart DA. Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine (2007). http://medicine.iupui.edu/flockhart/table.htm. Accessed [29-09-2007]&amp;lt;/ref&amp;gt;&#039;&#039; &lt;br /&gt;
!bgcolor=&amp;quot;#D3D3D3&amp;quot;|Potent inducers !! bgcolor=&amp;quot;#D3D3D3&amp;quot;|Potent inhibitors !! bgcolor=&amp;quot;#D3D3D3&amp;quot;|Substrates&lt;br /&gt;
|-&lt;br /&gt;
| [[Rifampicin]], [[Carbamazepine]], &amp;lt;br /&amp;gt;[[Phenobarbital]], [[Phenytoin]], &amp;lt;br /&amp;gt;([[St John&#039;s wort]]), || [[Amiodarone]], [[cimetidine]], &amp;lt;br /&amp;gt;[[ciprofloxacin]], [[fluconazole]],&amp;lt;br /&amp;gt; [[fluoxetine]], [[erythromycin]], &amp;lt;br /&amp;gt;[[isoniazid]], [[diltiazem]] ||[[Caffeine]], [[clozapine]],&amp;lt;br /&amp;gt; [[omeprazole]], [[losartan]],&amp;lt;br /&amp;gt;[[theophylline]]&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
2. Change in enzyme activity: Many substances can influence  P-450 enzyme mechanism. Drugs interact with the enzyme family in several ways.&amp;lt;ref name=&amp;quot;pmid9469685&amp;quot;&amp;gt;{{cite journal |author=Michalets EL |title=Update: clinically significant cytochrome P-450 drug interactions |journal=Pharmacotherapy |volume=18 |issue=1 |pages=84–112 |year=1998 |pmid=9469685 |doi=}}&amp;lt;/ref&amp;gt; Drugs that modify Cytochrome P-450 enzyme are referred to as either inhibitors or inducers. Enzyme inhibitors block the metabolic activity of one or several P-450 enzymes. This effect usually occurs immediately. On the other hand inducers increase P-450 activity by increasing its synthesis. Depending on inducing drug&#039;s half life, there is usually a delay before enzyme activity increases.&amp;lt;ref name=&amp;quot;pmid17708140&amp;quot;/&amp;gt;&lt;br /&gt;
&lt;br /&gt;
3. Competitive inhibition: Some drugs may share the same P-450 specificity and thus competitively block their bio transformation. This may lead to accumulation of drugs metabolised by the enzyme. This type of drug interaction may also  reduce the rate of generation of toxic substrate.&lt;br /&gt;
&lt;br /&gt;
=== Patterns of Injury===&lt;br /&gt;
&lt;br /&gt;
{| style=&amp;quot;padding:0.3em; float:right; margin-left:5px; border:1px solid #A3B1BF;background:#E0FFFF;&amp;quot;&lt;br /&gt;
|+ &#039;&#039;Patterns of drug-induced liver disease&#039;&#039; &lt;br /&gt;
!bgcolor=&amp;quot;#B0C4DE&amp;quot;|Type of injury: !! bgcolor=&amp;quot;#B0C4DE&amp;quot;|Hepatocellular !! bgcolor=&amp;quot;#B0C4DE&amp;quot;|Cholestatic!!bgcolor=&amp;quot;#B0C4DE&amp;quot;|Mixed&lt;br /&gt;
|-&lt;br /&gt;
![[ALT]]&lt;br /&gt;
| ≥ Twofold rise|| Normal||≥ Twofold rise &lt;br /&gt;
|-&lt;br /&gt;
![[Alkaline phosphatase|ALP]]&lt;br /&gt;
|Normal ||≥ Twofold rise||≥ Twofold rise&lt;br /&gt;
|-&lt;br /&gt;
!ALT: ALP ratio&lt;br /&gt;
|High, ≥5|| Low, ≤2||2-5&lt;br /&gt;
|-&lt;br /&gt;
!Examples&amp;lt;ref name=&amp;quot;pmid16710915&amp;quot;&amp;gt;{{cite journal |author=Mumoli N, Cei M, Cosimi A |title=Drug-related hepatotoxicity |journal=N. Engl. J. Med. |volume=354 |issue=20 |pages=2191-3; author reply 2191-3 |year=2006 |pmid=16710915 |doi=}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
|[[Acetaminophen]]&amp;lt;br /&amp;gt;[[Allopurinol]]&amp;lt;br /&amp;gt;[[Amiodarone]]&amp;lt;br /&amp;gt;[[HAART]]&amp;lt;br /&amp;gt;[[NSAID]]||[[Anabolic steroid]]&amp;lt;br /&amp;gt;[[Chlorpromazine]]&amp;lt;br /&amp;gt;[[Clopidogrel]]&amp;lt;br /&amp;gt;[[Erythromycin]]&amp;lt;br /&amp;gt;[[Hormonal contraception]]||[[Amitryptyline]],&amp;lt;br /&amp;gt;[[Enalapril]]&amp;lt;br /&amp;gt;[[Carbamazepine]]&amp;lt;br /&amp;gt;[[Sulphonamide]]&amp;lt;br /&amp;gt;[[Phenytoin]]&lt;br /&gt;
|}&lt;br /&gt;
Chemicals produce a wide variety of [[clinical]] and [[pathological]] hepatic injury. Biochemical markers (i.e. [[alanine transferase]], [[alkaline phosphatase]] and [[bilirubin]]) are often used to indicate liver damage. Liver injury is defined as rise in either (a) [[alanine transferase|ALT]] level more than three times of upper limit of normal (ULN), (b) [[alkaline phosphatase|ALP]] level more than twice ULN, or (c) total bilirubin level more than twice ULN when associated with increased ALT or ALP.&amp;lt;ref&amp;gt;{{cite journal |author=Bénichou C |title=Criteria of drug-induced liver disorders. Report of an international consensus meeting |journal=J. Hepatol. |volume=11 |issue=2 |pages=272–6 |year=1990 |pmid=2254635 |doi=}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid16710915&amp;quot;/&amp;gt; Liver damage is further characterized into hepatocellular (predominantly initial [[Alanine transferase]] elevation) and [[cholestatic]] (initial alkaline phosphatase rise) types. However they are not mutually exclusive and mixed type of injuries are often encountered. &lt;br /&gt;
&lt;br /&gt;
Specific [[Morphology (biology)|histo-pathological]] patterns of liver injury from drug induced damage are discussed below.&lt;br /&gt;
&lt;br /&gt;
*Zonal Necrosis: This is the most common type of drug induced liver cell [[necrosis]] where the injury is largely confined to a particular zone of the [[liver lobule]]. It may manifest as very high level of [[Alanine transaminase|ALT]] and severe disturbance of liver function leading to [[acute liver failure]].&lt;br /&gt;
:Causes: &lt;br /&gt;
:[[Acetaminophen|Acetaminophen (Tylenol)]], [[carbon tetrachloride]]&lt;br /&gt;
&lt;br /&gt;
*[[Hepatitis]]: In this pattern hepatocellular necrosis is associated with infiltration of inflammatory cells. There can be three types of drug induced hepatitis. (A) viral hepatitis type picture is the commonest, where histological features are similar to acute viral hepatitis. (B) in the focal or non specific hepatitis scattered foci of cell necrosis may accompany [[lymphocyte|lymphocytic]] infiltrate. (C) chronic hepatitis type is very similar to [[autoimmune hepatitis]] clinically, serologically as well as histologically.&lt;br /&gt;
:Causes: &lt;br /&gt;
:(a) Viral hepatitis like: [[Halothane]], [[Isoniazid]], [[Phenytoin]]&lt;br /&gt;
:(b) Focal hepatitis: [[Aspirin]]&lt;br /&gt;
:(c) Chronic hepatitis: [[Methyldopa]], [[Diclofenac]]&lt;br /&gt;
&lt;br /&gt;
*[[Cholestasis]]: Liver injury leads to impairment of bile flow and clinical picture is predominated by itching and jaundice. Histology may show inflammation (cholestatic hepatitis) or it can be bland without any [[parenchymal]] inflammation. In rare occasions it can produce features similar to primary biliary cirrhosis due to progressive destruction of small bile ducts (Vanishing duct syndrome).&lt;br /&gt;
:Causes:&lt;br /&gt;
:(a) Bland: [[Combined oral contraceptive pill|Oral contraceptive pills]], [[anabolic steroid]], [[Androgens]]&lt;br /&gt;
:(b) Inflammatory: [[Allopurinol]], [[Co-amoxiclav]], [[Carbamazepine]]&lt;br /&gt;
:(c) Ductal: [[Chlorpromazine]], [[flucloxacillin]]&lt;br /&gt;
&lt;br /&gt;
*[[Steatosis]]: Hepatotoxicity may manifest as triglyceride accumulation which leads to either small droplet (microvesicular) or large droplet (macrovesicular) fatty liver. There is a separate type of steatosis where phospholipid accumulation leads to a pattern similar to the diseases with inherited phospholipid metabolism defects (e.g. [[Tay-Sachs disease]])&lt;br /&gt;
:Causes:&lt;br /&gt;
:(a) Microvesicular: [[Aspirin]] ([[Reye&#039;s syndrome]]), [[Ketoprofen]], [[Tetracycline]]&lt;br /&gt;
:(b) Macrovesicular: [[Acetamenophen]], [[methotrexate]]&lt;br /&gt;
:(c) Phospholipidosis: [[Amiodarone]], [[Total parenteral nutrition]]&lt;br /&gt;
&lt;br /&gt;
*[[Granuloma]]: Drug induced hepatic granulomas are usually associated with granulomas in other tissues and patients typically have features of systemic vasculitis and hypersensitivity. More than 50 drugs have been implicated.&lt;br /&gt;
: Causes:&lt;br /&gt;
:[[Allopurinol]], [[Phenytoin]], [[Isoniazid]], [[Quinine]], [[Penicillin]], [[Quinidine]]&lt;br /&gt;
&lt;br /&gt;
*Vascular lesions: They result from injury to the vascular endothelium.&lt;br /&gt;
:Causes:&lt;br /&gt;
:[[Venoocclusive disease]]: Chemotherapeutic agents, bush tea&lt;br /&gt;
:[[Peliosis hepatis]]: anabolic steroid&lt;br /&gt;
:[[Budd-Chiari syndrome|Hepatic vein thrombosis]]: Oral contraceptives&lt;br /&gt;
&lt;br /&gt;
*[[Neoplasm]]: Neoplasms have been described with prolonged exposure to some medications or toxins. Hepatocellular carcinoma, angiosarcoma and liver adenomas are the ones usually reported.&lt;br /&gt;
:Causes: &lt;br /&gt;
:[[Vinyl chloride]], [[Combined oral contraceptive pill]],[[Anabolic steroid]], [[Arsenic]], [[Thorotrast]]&lt;br /&gt;
&lt;br /&gt;
==Pathology==&lt;br /&gt;
&lt;br /&gt;
===Gross Pathology===&lt;br /&gt;
On gross pathology, [[Link|steatosis]], fibrosis, and even [[Link|cirrhosis]] can be caused by drug induced liver injury. &lt;br /&gt;
&lt;br /&gt;
===Microscopic Pathology===&lt;br /&gt;
On microscopic histopathological analysis, there are three main patterns of drug induced liver injury:&amp;lt;ref name=&amp;quot;pmid19474352&amp;quot;&amp;gt;{{cite journal| author=Ramachandran R, Kakar S| title=Histological patterns in drug-induced liver disease. | journal=J Clin Pathol | year= 2009 | volume= 62 | issue= 6 | pages= 481-92 | pmid=19474352 | doi=10.1136/jcp.2008.058248 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=19474352  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
====Necrosis with severe inflammation====&lt;br /&gt;
*most common pattern in idiosyncratic drug induced liver injury. Involves most of the liver parenchyma. &lt;br /&gt;
*example inciting drugs: antiepileptics indlucing phenytoin and valproic acid, monoamine oxidase inhibitors, and isoniazid as well as other antimicrobials including sulfonamides and azoles  &lt;br /&gt;
====Necrosis with little to no inflammation====&lt;br /&gt;
*example inciting drugs: recreational drugs including cocaine and 3,4-methylenedioxymethylamphetamine (ecstasy), industrial organic compounds such as carbon tetrachloride, and some herbal preparations&lt;br /&gt;
====Extensive Microvesicular Steatosis====&lt;br /&gt;
*most rare; can be accompanied by necrosis&lt;br /&gt;
*example inciting drugs: tetracycline, nucleoside analogues (e.g. zidovudine). See [[Link|steatosis]], [[Link|fatty liver]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_risk_factors&amp;diff=1262489</id>
		<title>Drug induced liver injury risk factors</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_risk_factors&amp;diff=1262489"/>
		<updated>2016-10-19T21:03:58Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Various risk factors have been associated with drug induced liver injury. However, most reactions are idiosyncratic and do not follow predictable responses, making it difficult to predict the risk of liver injury from a given drug in an individual patient.&lt;br /&gt;
&lt;br /&gt;
==Risk Factors== &lt;br /&gt;
* Age: Apart from accidental exposure, hepatic drug reactions are rare in children. Elderly persons are at increased risk of hepatic injury because of decreased clearance, drug-to-drug interactions, reduced hepatic blood flow, variation in drug binding, and lower hepatic volume. In addition, poor diet, infections, and multiple hospitalizations are important reasons for drug-induced hepatotoxicity.&lt;br /&gt;
* Alcohol ingestion: Alcoholic persons are susceptible to drug toxicity because alcohol induces liver injury and cirrhotic changes that alter drug metabolism. Alcohol causes depletion of glutathione (hepatoprotective) stores that make the person more susceptible to toxicity by drugs.&lt;br /&gt;
* Drug formulation: Long-acting drugs may cause more injury than shorter-acting drugs.&lt;br /&gt;
* Gender: Although the reasons are unknown, hepatic drug reactions are more common in females.&lt;br /&gt;
* Genetic factors: A unique gene encodes each P-450 protein. Genetic differences in the P-450 enzymes can result in abnormal reactions to drugs, including idiosyncratic reactions. Debrisoquine is an antiarrhythmic drug that undergoes poor metabolism because of abnormal expression of P-450-II-D6. This can be identified by polymerase chain reaction amplification of mutant genes. This has led to the possibility of future detection of persons who can have abnormal reactions to a drug.&lt;br /&gt;
* Host factors that may enhance susceptibility to drugs, possibly inducing liver disease:&lt;br /&gt;
:* [[AIDS]] - [[Dapsone]], [[trimethoprim-sulfamethoxazole]]&lt;br /&gt;
:* [[Diabetes mellitus]] - [[Methotrexate]], [[niacin]]&lt;br /&gt;
:* [[Fasting]] or [[malnutrition]] - [[Acetaminophen]]&lt;br /&gt;
:* [[Female]] - [[Halothane]], [[nitrofurantoin]], [[sulindac]]&lt;br /&gt;
:* [[Hepatitis C]] - [[Ibuprofen]], [[ritonavir]], [[flutamide]]&lt;br /&gt;
:* Large [[body mass index]] / [[obesity]] - [[Halothane]]&lt;br /&gt;
:* [[Male]] - [[Amoxicillin-clavulanic acid]] ([[Augmentin]])&lt;br /&gt;
:* [[Old age]] - [[Acetaminophen]], [[halothane]], [[INH]], [[amoxicillin-clavulanic acid]]&lt;br /&gt;
:* Preexisting [[liver disease]] - [[Niacin]], [[tetracycline]], [[methotrexate]]&lt;br /&gt;
:* [[Renal failure]] - [[Tetracycline]], [[allopurinol]]&lt;br /&gt;
:* Young age - [[Salicylate]]s, [[valproic acid]]&lt;br /&gt;
* [[Liver disease]]: In general, patients with chronic liver disease are not uniformly at increased risk of hepatic injury. Although the total cytochrome P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; is reduced, some may be affected more than others. The modification of doses in persons with liver disease should be based on the knowledge of the specific enzyme involved in the metabolism. Patients with HIV infection who are co-infected with hepatitis B or C virus are at increased risk for hepatotoxic effects when treated with antiretroviral therapy. Similarly, patients with cirrhosis are at increased risk of decompensation by toxic drugs.&lt;br /&gt;
* Other comorbidities: Persons with AIDS, persons who are malnourished, and persons who are fasting may be susceptible to drug reactions because of low glutathione stores.&lt;br /&gt;
* [[Race]]: Some drugs appear to have different toxicities based on race. For example, African Americans and Hispanics may be more susceptible to isoniazid (INH) toxicity. The rate of metabolism is under the control of P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; enzymes and can vary from individual to individual.&lt;br /&gt;
&lt;br /&gt;
===Drugs that Effect Cytochrome P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Inducers====&lt;br /&gt;
*[[Carbamazepine]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Glucocorticoids]]&lt;br /&gt;
*[[Griseofulvin]]&lt;br /&gt;
*[[Omeprazole]]  (Induces P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; 1A2)&lt;br /&gt;
*[[Phenobarbital]]&lt;br /&gt;
*[[Phenytoin]]&lt;br /&gt;
*[[Primidone]]&lt;br /&gt;
*[[Quinine]]&lt;br /&gt;
*[[Rifampin]]&lt;br /&gt;
&lt;br /&gt;
====Inhibitors====&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Cimetidine]]&lt;br /&gt;
*[[Erythromycin]]&lt;br /&gt;
*Grape fruit&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
*[[Ketoconazole]]&lt;br /&gt;
*[[Metronidazole]]&lt;br /&gt;
*[[Omeprazole]]  (Inhibits P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; 2C8)&lt;br /&gt;
*[[Quinidine]]&lt;br /&gt;
*[[Sulfonamide]]s&lt;br /&gt;
&lt;br /&gt;
===Drugs which cause Hepatotoxicity&amp;lt;ref&amp;gt;PMID 17230599&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;pmid10687025&amp;quot;&amp;gt;{{cite journal |author=Shah RR |title=Drug-induced hepatotoxicity: pharmacokinetic perspectives and strategies for risk reduction |journal=Adverse drug reactions and toxicological reviews |volume=18 |issue=4 |pages=181–233 |year=1999 |pmid=10687025 |doi=}}&amp;lt;/ref&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
*[[Troglitazone]]&lt;br /&gt;
*[[Bromfenac]]&lt;br /&gt;
*[[Trovafloxacin]]&lt;br /&gt;
*Ebrotidine&lt;br /&gt;
*[[Nimesulide]]&lt;br /&gt;
*[[Nefazodone]]&lt;br /&gt;
*[[Ximelagatran]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_risk_factors&amp;diff=1262488</id>
		<title>Drug induced liver injury risk factors</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_risk_factors&amp;diff=1262488"/>
		<updated>2016-10-19T21:03:13Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Various risk factors have been associated with drug induced liver injury. However, most reactions are idiosyncratic and do not follow predictable responses, making it difficult to predict risk of liver injury from a given drug in an individual patient.&lt;br /&gt;
&lt;br /&gt;
==Risk Factors== &lt;br /&gt;
* Age: Apart from accidental exposure, hepatic drug reactions are rare in children. Elderly persons are at increased risk of hepatic injury because of decreased clearance, drug-to-drug interactions, reduced hepatic blood flow, variation in drug binding, and lower hepatic volume. In addition, poor diet, infections, and multiple hospitalizations are important reasons for drug-induced hepatotoxicity.&lt;br /&gt;
* Alcohol ingestion: Alcoholic persons are susceptible to drug toxicity because alcohol induces liver injury and cirrhotic changes that alter drug metabolism. Alcohol causes depletion of glutathione (hepatoprotective) stores that make the person more susceptible to toxicity by drugs.&lt;br /&gt;
* Drug formulation: Long-acting drugs may cause more injury than shorter-acting drugs.&lt;br /&gt;
* Gender: Although the reasons are unknown, hepatic drug reactions are more common in females.&lt;br /&gt;
* Genetic factors: A unique gene encodes each P-450 protein. Genetic differences in the P-450 enzymes can result in abnormal reactions to drugs, including idiosyncratic reactions. Debrisoquine is an antiarrhythmic drug that undergoes poor metabolism because of abnormal expression of P-450-II-D6. This can be identified by polymerase chain reaction amplification of mutant genes. This has led to the possibility of future detection of persons who can have abnormal reactions to a drug.&lt;br /&gt;
* Host factors that may enhance susceptibility to drugs, possibly inducing liver disease:&lt;br /&gt;
:* [[AIDS]] - [[Dapsone]], [[trimethoprim-sulfamethoxazole]]&lt;br /&gt;
:* [[Diabetes mellitus]] - [[Methotrexate]], [[niacin]]&lt;br /&gt;
:* [[Fasting]] or [[malnutrition]] - [[Acetaminophen]]&lt;br /&gt;
:* [[Female]] - [[Halothane]], [[nitrofurantoin]], [[sulindac]]&lt;br /&gt;
:* [[Hepatitis C]] - [[Ibuprofen]], [[ritonavir]], [[flutamide]]&lt;br /&gt;
:* Large [[body mass index]] / [[obesity]] - [[Halothane]]&lt;br /&gt;
:* [[Male]] - [[Amoxicillin-clavulanic acid]] ([[Augmentin]])&lt;br /&gt;
:* [[Old age]] - [[Acetaminophen]], [[halothane]], [[INH]], [[amoxicillin-clavulanic acid]]&lt;br /&gt;
:* Preexisting [[liver disease]] - [[Niacin]], [[tetracycline]], [[methotrexate]]&lt;br /&gt;
:* [[Renal failure]] - [[Tetracycline]], [[allopurinol]]&lt;br /&gt;
:* Young age - [[Salicylate]]s, [[valproic acid]]&lt;br /&gt;
* [[Liver disease]]: In general, patients with chronic liver disease are not uniformly at increased risk of hepatic injury. Although the total cytochrome P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; is reduced, some may be affected more than others. The modification of doses in persons with liver disease should be based on the knowledge of the specific enzyme involved in the metabolism. Patients with HIV infection who are co-infected with hepatitis B or C virus are at increased risk for hepatotoxic effects when treated with antiretroviral therapy. Similarly, patients with cirrhosis are at increased risk of decompensation by toxic drugs.&lt;br /&gt;
* Other comorbidities: Persons with AIDS, persons who are malnourished, and persons who are fasting may be susceptible to drug reactions because of low glutathione stores.&lt;br /&gt;
* [[Race]]: Some drugs appear to have different toxicities based on race. For example, African Americans and Hispanics may be more susceptible to isoniazid (INH) toxicity. The rate of metabolism is under the control of P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; enzymes and can vary from individual to individual.&lt;br /&gt;
&lt;br /&gt;
===Drugs that Effect Cytochrome P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
====Inducers====&lt;br /&gt;
*[[Carbamazepine]]&lt;br /&gt;
*[[Ethanol]]&lt;br /&gt;
*[[Glucocorticoids]]&lt;br /&gt;
*[[Griseofulvin]]&lt;br /&gt;
*[[Omeprazole]]  (Induces P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; 1A2)&lt;br /&gt;
*[[Phenobarbital]]&lt;br /&gt;
*[[Phenytoin]]&lt;br /&gt;
*[[Primidone]]&lt;br /&gt;
*[[Quinine]]&lt;br /&gt;
*[[Rifampin]]&lt;br /&gt;
&lt;br /&gt;
====Inhibitors====&lt;br /&gt;
*[[Amiodarone]]&lt;br /&gt;
*[[Cimetidine]]&lt;br /&gt;
*[[Erythromycin]]&lt;br /&gt;
*Grape fruit&lt;br /&gt;
*[[Isoniazid]]&lt;br /&gt;
*[[Ketoconazole]]&lt;br /&gt;
*[[Metronidazole]]&lt;br /&gt;
*[[Omeprazole]]  (Inhibits P&amp;lt;sub&amp;gt;450&amp;lt;/sub&amp;gt; 2C8)&lt;br /&gt;
*[[Quinidine]]&lt;br /&gt;
*[[Sulfonamide]]s&lt;br /&gt;
&lt;br /&gt;
===Drugs which cause Hepatotoxicity&amp;lt;ref&amp;gt;PMID 17230599&amp;lt;/ref&amp;gt; &amp;lt;ref name=&amp;quot;pmid10687025&amp;quot;&amp;gt;{{cite journal |author=Shah RR |title=Drug-induced hepatotoxicity: pharmacokinetic perspectives and strategies for risk reduction |journal=Adverse drug reactions and toxicological reviews |volume=18 |issue=4 |pages=181–233 |year=1999 |pmid=10687025 |doi=}}&amp;lt;/ref&amp;gt;===&lt;br /&gt;
&lt;br /&gt;
*[[Troglitazone]]&lt;br /&gt;
*[[Bromfenac]]&lt;br /&gt;
*[[Trovafloxacin]]&lt;br /&gt;
*Ebrotidine&lt;br /&gt;
*[[Nimesulide]]&lt;br /&gt;
*[[Nefazodone]]&lt;br /&gt;
*[[Ximelagatran]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262487</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262487"/>
		<updated>2016-10-19T20:58:59Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Laboratory Findings */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: [[Drug induced liver injury differential diagnosis|Differential Diagnosis]]). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury (see also: [[Drug induced liver injury classification|Classification]]).&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury or cases of severe acute liver injury leading to abnormal synthetic function&lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], may be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[primary biliary cirrhosis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1262486</id>
		<title>Drug induced liver injury differential diagnosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1262486"/>
		<updated>2016-10-19T20:57:21Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Drug induced liver injury must be differentiated from other diseases that cause serum transaminase elevations and [[Drug_induced_liver_injury_history_and_symptoms|symptoms]] of acute liver injury&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
&lt;br /&gt;
The following diseases are in the differential of drug induced liver injury:&lt;br /&gt;
* [[Acute viral hepatitis]]&lt;br /&gt;
* [[Alcoholic liver disease]]&lt;br /&gt;
* [[Autoimmune hepatitis]]&lt;br /&gt;
* [[Budd-Chiari syndrome]]&lt;br /&gt;
* [[Cholangitis]]&lt;br /&gt;
* [[Cholecystitis]]&lt;br /&gt;
* [[Cholestatic liver disease]]&lt;br /&gt;
* [[Coagulation disorders]]&lt;br /&gt;
* [[Hemochromatosis]]&lt;br /&gt;
* [[Malignancy]]&lt;br /&gt;
* [[Pregnancy-related conditions of liver]]&lt;br /&gt;
* [[Shock liver]]&lt;br /&gt;
* [[Wilson disease]]&lt;br /&gt;
&lt;br /&gt;
Some medications (e.g. [[minocycline]], [[nitrofurantoin]]) cause autoimmune-like drug induced liver injury, which must be distinguished from [[autoimmune hepatitis]] using serum studies such as antinuclear antibody, immunoglobulin G, and anti-smooth muscle antibody.&lt;br /&gt;
&lt;br /&gt;
In patients below the age of forty, it may also be worth screening for [[Wilson&#039;s Disease]], though rare, with serum ceruloplasmin. However, ceruloplasmin may also be falsely normal or even elevated as an acute-phase reactant during episodes of acute hepatitis. Further testing if indicated would include slit lamp examination and 24-hour urine copper collection.&lt;br /&gt;
&lt;br /&gt;
If tender hepatomegaly and ascites are present, ultrasound with doppler should be obtained to assess for [[Budd-Chiari syndrome]].&lt;br /&gt;
&lt;br /&gt;
Other etiologies that may have overlapping presentations with cholestatic liver injury include:&lt;br /&gt;
*Extrahepatic etiologies:&lt;br /&gt;
**[[Choledocholithiasis]]&lt;br /&gt;
**Malignancy (e.g. lymphoma)&lt;br /&gt;
*Intrahepatic etiologies&lt;br /&gt;
**[[Primary biliary cirrhosis]]&lt;br /&gt;
**[[Primary sclerosing cholangitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262485</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262485"/>
		<updated>2016-10-19T20:55:07Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: [[Drug induced liver injury differential diagnosis|Differential Diagnosis]]). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury (see also: [[Drug induced liver injury classification|Classification]]).&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], will be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262484</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262484"/>
		<updated>2016-10-19T20:54:00Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: [[http://www.wikidoc.org/index.php/Drug_induced_liver_injury_differential_diagnosis Differential Diagnosis]]). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury (see also: [[Drug induced liver injury classification]]).&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], will be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_classification&amp;diff=1262483</id>
		<title>Drug induced liver injury classification</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_classification&amp;diff=1262483"/>
		<updated>2016-10-19T20:51:54Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are various classification systems in place for drug induced liver injury.&amp;lt;ref name=&amp;quot;pmid26125428&amp;quot;&amp;gt;{{cite journal| author=Fisher K, Vuppalanchi R, Saxena R| title=Drug-Induced Liver Injury. | journal=Arch Pathol Lab Med | year= 2015 | volume= 139 | issue= 7 | pages= 876-87 | pmid=26125428 | doi=10.5858/arpa.2014-0214-RA | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=26125428  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Classification==&lt;br /&gt;
Drug induced liver injury may be classified into multiple subtypes based on clinical presentation, mechanism, or histologic findings.&lt;br /&gt;
===Clinical presentation:===&lt;br /&gt;
====Hepatocellular injury====&lt;br /&gt;
*elevation of serum transaminases ≥ 2-5 times the upper limit of normal&lt;br /&gt;
*may have hyperbilirubinemia&lt;br /&gt;
*may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin)&lt;br /&gt;
====Cholestatic injury====&lt;br /&gt;
*elevation of alkaline phosphatase ≥ 3 times the upper limit of normal&lt;br /&gt;
*may have hyperbilirubinemia&lt;br /&gt;
*may have abnormal synthetic function tests (e.g. International Normalized Ratio, albumin)&lt;br /&gt;
====Mixed injury====&lt;br /&gt;
*both alkaline phosphatase and transaminases are elevated in roughly equal proportion, and/or an alanine aminotransferase to alkaline phosphatase ratio between 2-5&lt;br /&gt;
&lt;br /&gt;
===Mechanism:===&lt;br /&gt;
====Dose-dependent hepatotoxicity====&lt;br /&gt;
*e.g. acetaminophen-induced centrilobular necrosis&lt;br /&gt;
====Idiosyncratic hepatotoxicity====&lt;br /&gt;
*e.g. stimulation of immune reponse by biologic agents, independent of dose, akin to drug hypersensitivity&lt;br /&gt;
*e.g. altered host genes involved in drug metabolism&lt;br /&gt;
&lt;br /&gt;
===Histologic findings:===&lt;br /&gt;
====Hepatitis (hepatocellular injury)====&lt;br /&gt;
====Cholestasis====&lt;br /&gt;
====Granulomatous====&lt;br /&gt;
====Steatosis====&lt;br /&gt;
====Fibrosis====&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262482</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262482"/>
		<updated>2016-10-19T20:49:42Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: [[http://www.wikidoc.org/index.php/Drug_induced_liver_injury_differential_diagnosis Differential Diagnosis]]). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury.&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], will be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262481</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262481"/>
		<updated>2016-10-19T20:48:03Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: [[http://www.wikidoc.org/index.php/Drug_induced_liver_injury_differential_diagnosis|&amp;quot;Differential Diagnosis&amp;quot;]]). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury.&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], will be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262480</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262480"/>
		<updated>2016-10-19T20:47:20Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: [[http://www.wikidoc.org/index.php/Drug_induced_liver_injury_differential_diagnosis|Differential Diagnosis]]). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury.&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], will be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262479</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262479"/>
		<updated>2016-10-19T20:44:30Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests help assess the severity of illness as well as help distinguish drug induced liver injury from other pathologies (see also: Differential diagnosis|http://www.wikidoc.org/index.php/Drug_induced_liver_injury_differential_diagnosis). Patterns of abnormalities can also distinguish between hepatocellular and cholestatic liver injury.&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained in all cases of suspected drug induced liver injury:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated (≥ 2 times the upper limit of normal) compared to aminotransferases in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): will be elevated ≥ 3 times the upper limit of normal in hepatocellular injury cases, and even &amp;gt; 20 times the upper limit of normal in acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], will be elevated due to coagulopathy from either hepatocellular or cholestatic injury&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
The following tests are also helpful in patients presenting with autoimmune-like features:&lt;br /&gt;
* [[Antinuclear antibody]]&lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262478</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262478"/>
		<updated>2016-10-19T20:37:04Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory tests reflect whether the liver injury is more hepatocellular or cholestatic in nature.&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained to assess the severity of illness as well as distinguish drug induced liver injury from other pathologies:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions e.g. [[DRESS]], or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated compared to aminotransferases below in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): can be markedly elevated (&amp;gt; 20 times the upper limit of normal) in cases of acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): can be markedly elevated (&amp;gt; 20 times the upper limit of normal) in cases of acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], particularly after administration of [[vitamin K]] &lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262477</id>
		<title>Drug induced liver injury laboratory findings</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_laboratory_findings&amp;diff=1262477"/>
		<updated>2016-10-19T20:35:47Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{Rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Laboratory finding reflects whether the liver injury is more hepatocellular or cholestatic in nature.&lt;br /&gt;
&lt;br /&gt;
==Laboratory Findings==&lt;br /&gt;
The following laboratory tests should be obtained to assess the severity of illness as well as distinguish drug induced liver injury from other pathologies:&lt;br /&gt;
&lt;br /&gt;
* [[CBC]] with differential: may reveal eosinophilia in hypersensitivity reactions, or lymphocytosis (with atypical lymphocytes on smear) in mononucleosis-like illnesses&lt;br /&gt;
* [[Alkaline phosphatase]]: will be disproportionately elevated compared to aminotransferases below in cholestatic injury&lt;br /&gt;
* [[AST]] / [[serum glutamic oxaloacetic transaminase]] ([[SGOT]]): can be markedly elevated (&amp;gt; 20 times the upper limit of normal) in cases of acute hepatocellular injury&lt;br /&gt;
* [[ALT]] / [[serum glutamic pyruvate transaminase]] ([[SGPT]]): can be markedly elevated (&amp;gt; 20 times the upper limit of normal) in cases of acute hepatocellular injury&lt;br /&gt;
* [[Albumin]]: will be low in chronic liver injury &lt;br /&gt;
* [[Bilirubin]]: may be elevated in both hepatocellular and cholestatic injury&lt;br /&gt;
* [[Prothrombin time]], particularly after administration of [[vitamin K]] &lt;br /&gt;
* [[Anti-mitochondrial antibody]] ([[AMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Anti smooth muscle antibody]] ([[ASMA]]) to distinguish from [[autoimmune hepatitis]]&lt;br /&gt;
* [[Urinalysis]] to assess bilirubinuria&lt;br /&gt;
* Drug levels, e.g. acetaminophen serum level&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_surgery&amp;diff=1258654</id>
		<title>Drug induced liver injury surgery</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_surgery&amp;diff=1258654"/>
		<updated>2016-10-06T11:49:27Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The role of surgery in the treatment of drug induced liver injury is limited to liver transplanation in cases of severe, even life-threatening injury or for patients in whom there are no signs of spontaneous recovery. Otherwise, surgical intervention is not recommended given that 90% of cases of acute drug liver injury resolve without sequelae (see [[Drug_induced_liver_injury_natural_history,_complications_and_prognosis|prognosis]]).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1258653</id>
		<title>Drug induced liver injury medical therapy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1258653"/>
		<updated>2016-10-06T11:44:30Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The mainstay of therapy for drug induced liver injury is prompt withdrawal of the offending drug. &lt;br /&gt;
&lt;br /&gt;
==Medical Therapy==&lt;br /&gt;
It has been hypothesized that early drug withdrawal prevents progression to acute liver failure, but there is insufficient data to support this, as sometimes even a few days of exposure to a drug can cause a fatal outcome.&lt;br /&gt;
&lt;br /&gt;
There is no antidote approved by the Federal Drug Administration for idiosyncratic drug induced liver injury. N-Acetylcysteine has only been approved for acetaminophen-induced liver injury, though a randomized placebo-controlled trial suggested that this therapy significantly improves transplant-free survival from non-acetaminophen drug induced liver injury: 58% with N-acetyl cysteine versus 27% with placebo.&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Corticosteroid therapy has also been proposed as treatment for acute liver failure resulting from drug induced liver injury. However, unlike for alcoholic and autoimmune hepatitis, there are no controlled trials to support this therapy for drug induced liver injury.  &lt;br /&gt;
&lt;br /&gt;
Symptoms such as pruritis can be managed with antihistamines including hydroxyzine and diphenhydramine. Ursodeoxycholic acid was also used in approximately 30% of patients in the DILIN prospective study, but there is no clear evidence to support this therapy.&amp;lt;ref name=&amp;quot;pmid18955056&amp;quot;&amp;gt;{{cite journal| author=Chalasani N, Fontana RJ, Bonkovsky HL, Watkins PB, Davern T, Serrano J et al.| title=Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. | journal=Gastroenterology | year= 2008 | volume= 135 | issue= 6 | pages= 1924-34, 1934.e1-4 | pmid=18955056 | doi=10.1053/j.gastro.2008.09.011 | pmc=3654244 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=18955056  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1258652</id>
		<title>Drug induced liver injury medical therapy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1258652"/>
		<updated>2016-10-06T11:44:18Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Medical Therapy */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The mainstay of therapy for drug induced liver injury is prompt withdrawal of the offending drug. &lt;br /&gt;
&lt;br /&gt;
==Medical Therapy==&lt;br /&gt;
It has been hypothesized that early drug withdrawal prevents progression to acute liver failure, but there is insufficient data to support this, as sometimes even a few days of exposure to a drug can cause a fatal outcome.&lt;br /&gt;
&lt;br /&gt;
There is no antidote approved by the Federal Drug Administration for idiosyncratic drug induced liver injury. N-Acetylcysteine has only been approved for acetaminophen-induced liver injury, though a randomized placebo-controlled trial suggested that this therapy significantly improves transplant-free survival from non-acetaminophen drug induced liver injury: 58% with N-acetyl cysteine versus 27% with placebo.&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Corticosteroid therapy has also been proposed as treatment for acute liver failure resulting from drug induced liver injury. However, unlike for alcoholic and autoimmune hepatitis, there are no controlled trials to support this therapy for drug induced liver injury.  &lt;br /&gt;
&lt;br /&gt;
Symptoms such as pruritis can be managed with antihistamines including hydroxyzine and diphenhydramine. Ursodeoxycholic acid was also used in approximately 30% of patients in the DILIN prospective study, but there is no clear evidence to support this therapy. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1258651</id>
		<title>Drug induced liver injury medical therapy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1258651"/>
		<updated>2016-10-06T11:40:23Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The mainstay of therapy for drug induced liver injury is prompt withdrawal of the offending drug. &lt;br /&gt;
&lt;br /&gt;
==Medical Therapy==&lt;br /&gt;
It has been hypothesized that early drug withdrawal prevents progression to acute liver failure, but there is insufficient data to support this, as sometimes even a few days of exposure to a drug can cause a fatal outcome.&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
There is no antidote approved by the Federal Drug Administration for idiosyncratic drug induced liver injury. N-Acetylcysteine has only been approved for acetaminophen-induced liver injury, though a randomized placebo-controlled trial suggested that this therapy significantly improves transplant-free survival from drug induced liver injury: 58% with N-acetyl cysteine versus 27% with placebo.&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
Corticosteroid therapy has also been proposed as treatment for acute liver failure resulting from drug induced liver injury, but there are no controlled trials to support this therapy, unlike for alcoholic or autoimmune hepatitis. Symptoms such as pruritis can be managed with antihistamines including hydroxyzine and diphenhydramine. Ursodeoxycholic acid was also used in approximately 30% of patients in the DILIN prospective study, but there is no clear evidence to support this therapy. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1249593</id>
		<title>Drug induced liver injury medical therapy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_medical_therapy&amp;diff=1249593"/>
		<updated>2016-08-12T23:39:47Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The mainstay of therapy for drug induced liver injury is prompt withdrawal of the offending drug. &lt;br /&gt;
&lt;br /&gt;
==Medical Therapy==&lt;br /&gt;
It has been hypothesized that early drug withdrawal prevents progression to acute liver failure, but there is insufficient data to support this, as sometimes even a few days of exposure to a drug can cause a fatal outcome.&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_surgery&amp;diff=1249592</id>
		<title>Drug induced liver injury surgery</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_surgery&amp;diff=1249592"/>
		<updated>2016-08-12T23:24:07Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The role of surgery in the treatment of drug induced liver injury is limited to liver transplanation in cases of severe, even life-threatening injury. Otherwise, surgical intervention is not recommended given that 90% of cases of acute drug liver injury resolve without sequelae (see [[Drug_induced_liver_injury_natural_history,_complications_and_prognosis|prognosis]]).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_surgery&amp;diff=1249591</id>
		<title>Drug induced liver injury surgery</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_surgery&amp;diff=1249591"/>
		<updated>2016-08-12T23:23:43Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The role of surgery in the treatment of drug induced liver injury is limited to liver transplanation in cases of severe, even life-threatening injury. Otherwise, surgical intervention is not recommended given that 90% of cases of acute drug liver injury resolve without sequelae. (see [[Drug_induced_liver_injury_natural_history,_complications_and_prognosis|prognosis]]).&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1249590</id>
		<title>Drug induced liver injury differential diagnosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1249590"/>
		<updated>2016-08-12T23:13:43Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
Drug induced liver injury must be differentiated from other diseases that cause serum transaminase elevations and [[Drug_induced_liver_injury_history_and_symptoms|symptoms]] of acute liver injury&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
* [[Acute viral hepatitis]]&lt;br /&gt;
* [[Alcoholic liver disease]]&lt;br /&gt;
* [[Autoimmune hepatitis]]&lt;br /&gt;
* [[Budd-Chiari syndrome]]&lt;br /&gt;
* [[Cholangitis]]&lt;br /&gt;
* [[Cholecystitis]]&lt;br /&gt;
* [[Cholestatic liver disease]]&lt;br /&gt;
* [[Coagulation disorders]]&lt;br /&gt;
* [[Hemochromatosis]]&lt;br /&gt;
* [[Malignancy]]&lt;br /&gt;
* [[Pregnancy-related conditions of liver]]&lt;br /&gt;
* [[Shock liver]]&lt;br /&gt;
* [[Wilson disease]]&lt;br /&gt;
&lt;br /&gt;
Some medications (e.g. [[minocycline]], [[nitrofurantoin]]) cause autoimmune-like drug induced liver injury, which must be distinguished from [[autoimmune hepatitis]] using serum studies such as antinuclear antibody, immunoglobulin G, and anti-smooth muscle antibody.&lt;br /&gt;
&lt;br /&gt;
In patients below the age of forty, it may also be worth screening for [[Wilson&#039;s Disease]], though rare, with serum ceruloplasmin. However, ceruloplasmin may also be falsely normal or even elevated as an acute-phase reactant during episodes of acute hepatitis. Further testing if indicated would include slit lamp examination and 24-hour urine copper collection.&lt;br /&gt;
&lt;br /&gt;
If tender hepatomegaly and ascites are present, ultrasound with doppler should be obtained to assess for [[Budd-Chiari syndrome]].&lt;br /&gt;
&lt;br /&gt;
Other etiologies that may have overlapping presentations with cholestatic liver injury include:&lt;br /&gt;
*Extrahepatic etiologies:&lt;br /&gt;
**[[Choledocholithiasis]]&lt;br /&gt;
**Malignancy (e.g. lymphoma)&lt;br /&gt;
*Intrahepatic etiologies&lt;br /&gt;
**[[Primary biliary cirrhosis]]&lt;br /&gt;
**[[Primary sclerosing cholangitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1249589</id>
		<title>Drug induced liver injury differential diagnosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1249589"/>
		<updated>2016-08-12T23:12:53Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Differential Diagnosis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
Drug induced liver injury must be differentiated from other diseases that cause serum transaminase elevations and [[Drug_induced_liver_injury_history_and_symptoms|symptoms]] of acute liver injury&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;:&lt;br /&gt;
&lt;br /&gt;
* [[Acute viral hepatitis]]&lt;br /&gt;
* [[Alcoholic liver disease]]&lt;br /&gt;
* [[Autoimmune hepatitis]]&lt;br /&gt;
* [[Budd-Chiari syndrome]]&lt;br /&gt;
* [[Cholangitis]]&lt;br /&gt;
* [[Cholecystitis]]&lt;br /&gt;
* [[Cholestatic liver disease]]&lt;br /&gt;
* [[Coagulation disorders]]&lt;br /&gt;
* [[Hemochromatosis]]&lt;br /&gt;
* [[Malignancy]]&lt;br /&gt;
* [[Pregnancy-related conditions of liver]]&lt;br /&gt;
* [[Shock liver]]&lt;br /&gt;
* [[Wilson disease]]&lt;br /&gt;
&lt;br /&gt;
Some medications (e.g. [[minocycline]],[[nitrofurantoin]]) cause autoimmune-like drug induced liver injury, which must be distinguished from [[autoimmune hepatitis]] using serum studies such as antinuclear antibody, immunoglobulin G, and anti-smooth muscle antibody.&lt;br /&gt;
&lt;br /&gt;
In patients below the age of forty, it may also be worth screening for [[Wilson&#039;s Disease]], though rare, with serum ceruloplasmin. However, ceruloplasmin may also be falsely normal or even elevated as an acute-phase reactant during episodes of acute hepatitis. Further testing if indicated would include slit lamp examination and 24-hour urine copper collection.&lt;br /&gt;
&lt;br /&gt;
If tender hepatomegaly and ascites are present, ultrasound with doppler should be obtained to assess for [[Budd-Chiari syndrome]].&lt;br /&gt;
&lt;br /&gt;
Other etiologies that may have overlapping presentations with cholestatic liver injury include:&lt;br /&gt;
*Extrahepatic etiologies:&lt;br /&gt;
**[[Choledocholithiasis]]&lt;br /&gt;
**Malignancy (e.g. lymphoma)&lt;br /&gt;
*Intrahepatic etiologies&lt;br /&gt;
**[[Primary biliary cirrhosis]]&lt;br /&gt;
**[[Primary sclerosing cholangitis]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1249588</id>
		<title>Drug induced liver injury differential diagnosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_differential_diagnosis&amp;diff=1249588"/>
		<updated>2016-08-12T22:56:00Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Differential Diagnosis */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
&lt;br /&gt;
==Differential Diagnosis==&lt;br /&gt;
Drug induced liver injury must be differentiated from other diseases that cause serum transaminase elevations and other symptoms of acute liver injury, as detailed elsewhere [[Drug_induced_liver_injury_history_and_symptoms]]. &lt;br /&gt;
&lt;br /&gt;
* [[Acute viral hepatitis]]&lt;br /&gt;
* [[Alcoholic liver disease]]&lt;br /&gt;
* [[Autoimmune hepatitis]]&lt;br /&gt;
* [[Budd-Chiari syndrome]]&lt;br /&gt;
* [[Cholangitis]]&lt;br /&gt;
* [[Cholecystitis]]&lt;br /&gt;
* [[Cholestatic liver disease]]&lt;br /&gt;
* [[Coagulation disorders]]&lt;br /&gt;
* [[Hemochromatosis]]&lt;br /&gt;
* [[Malignancy]]&lt;br /&gt;
* [[Pregnancy-related conditions of liver]]&lt;br /&gt;
* [[Shock liver]]&lt;br /&gt;
* [[Wilson disease]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_ultrasound&amp;diff=1249587</id>
		<title>Drug induced liver injury ultrasound</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_ultrasound&amp;diff=1249587"/>
		<updated>2016-08-12T22:49:42Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
{{PleaseHelp}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Ultrasonography may demonstrate features of [[steatosis]], but there are no findings diagnostic of drug induced liver injury.&amp;lt;ref name=&amp;quot;pmid24935270&amp;quot;&amp;gt;{{cite journal| author=Chalasani NP, Hayashi PH, Bonkovsky HL, Navarro VJ, Lee WM, Fontana RJ et al.| title=ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 7 | pages= 950-66; quiz 967 | pmid=24935270 | doi=10.1038/ajg.2014.131 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24935270  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_ultrasound&amp;diff=1249586</id>
		<title>Drug induced liver injury ultrasound</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_ultrasound&amp;diff=1249586"/>
		<updated>2016-08-12T22:42:58Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}}&lt;br /&gt;
&lt;br /&gt;
{{PleaseHelp}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Ultrasonography may demonstrate features of [[steatosis]].&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_liver_biopsy&amp;diff=1249585</id>
		<title>Drug induced liver injury liver biopsy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_liver_biopsy&amp;diff=1249585"/>
		<updated>2016-08-12T22:26:11Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}} {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are no specific liver biopsy findings diagnostic of drug induced injury, but there are several broad histological patterns that reflect the type of injury caused by the inciting drug. Moreover, the same medication can induce a different pattern of liver injury depending on the patient.&lt;br /&gt;
&lt;br /&gt;
==Liver Biopsy==&lt;br /&gt;
The most common histological patterns seen in the drug induced liver injury network are as follows:&lt;br /&gt;
*Acute hepatitis (21%)&lt;br /&gt;
*Chronic hepatitis (14%)&lt;br /&gt;
*Cholestatic hepatitis (29%)&lt;br /&gt;
*Acute cholestasis (9%)&lt;br /&gt;
*Chronic cholestasis (10%)&lt;br /&gt;
&lt;br /&gt;
Patients presenting with hepatocellular injury tend to have evidence of severe inflammation, necrosism, hemorrhage, and rosette formation on biopsy. Patients with cholestatic injury tend to have more bile plugs and duct paucity. Certain findings on biopsy are predictive of severe and even fatal hepatic injury, including higher degrees of necrosis, microvesicular steatosis, fibrosis, and duct reactions. In contrast, eosinophils and granulomas are associated with milder injury.&amp;lt;ref name=&amp;quot;pmid24037963&amp;quot;&amp;gt;{{cite journal| author=Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB et al.| title=Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. | journal=Hepatology | year= 2014 | volume= 59 | issue= 2 | pages= 661-70 | pmid=24037963 | doi=10.1002/hep.26709 | pmc=3946736 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24037963  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
One example of a drug-specific histological finding is centrilobular necrosis characteristic of acetaminophen hepatotoxicity.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_MRI&amp;diff=1249584</id>
		<title>Drug induced liver injury MRI</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_MRI&amp;diff=1249584"/>
		<updated>2016-08-12T22:19:07Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are no magnetic resonance imaging findings associated with drug induced liver injury.&amp;lt;ref name=&amp;quot;pmid26159261&amp;quot;&amp;gt;{{cite journal| author=Watkins PB| title=How to Diagnose and Exclude Drug-Induced Liver Injury. | journal=Dig Dis | year= 2015 | volume= 33 | issue= 4 | pages= 472-6 | pmid=26159261 | doi=10.1159/000374091 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=26159261  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_CT&amp;diff=1249583</id>
		<title>Drug induced liver injury CT</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_CT&amp;diff=1249583"/>
		<updated>2016-08-12T22:14:10Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are no computerized tomography findings associated with drug induced liver injury.&amp;lt;ref name=&amp;quot;pmid26159261&amp;quot;&amp;gt;{{cite journal| author=Watkins PB| title=How to Diagnose and Exclude Drug-Induced Liver Injury. | journal=Dig Dis | year= 2015 | volume= 33 | issue= 4 | pages= 472-6 | pmid=26159261 | doi=10.1159/000374091 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=26159261  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_x_ray&amp;diff=1249582</id>
		<title>Drug induced liver injury x ray</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_x_ray&amp;diff=1249582"/>
		<updated>2016-08-12T21:50:32Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are no plain radiographic findings associated with drug induced liver injury.&amp;lt;ref name=&amp;quot;pmid26159261&amp;quot;&amp;gt;{{cite journal| author=Watkins PB| title=How to Diagnose and Exclude Drug-Induced Liver Injury. | journal=Dig Dis | year= 2015 | volume= 33 | issue= 4 | pages= 472-6 | pmid=26159261 | doi=10.1159/000374091 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=26159261  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;br /&gt;
&lt;br /&gt;
{{WS}}&lt;br /&gt;
{{WH}}&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_liver_biopsy&amp;diff=1249581</id>
		<title>Drug induced liver injury liver biopsy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_liver_biopsy&amp;diff=1249581"/>
		<updated>2016-08-12T21:35:35Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}} {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are no specific liver biopsy findings diagnostic of drug induced injury, but there are several broad histological patterns that reflect the type of injury caused by the inciting drug. &lt;br /&gt;
&lt;br /&gt;
==Liver Biopsy==&lt;br /&gt;
The most common histological patterns seen in the drug induced liver injury network are as follows:&lt;br /&gt;
*Acute hepatitis (21%)&lt;br /&gt;
*Chronic hepatitis (14%)&lt;br /&gt;
*Cholestatic hepatitis (29%)&lt;br /&gt;
*Acute cholestasis (9%)&lt;br /&gt;
*Chronic cholestasis (10%)&lt;br /&gt;
&lt;br /&gt;
Patients presenting with hepatocellular injury tend to have evidence of severe inflammation, necrosism, hemorrhage, and rosette formation on biopsy. Patients with cholestatic injury tend to have more bile plugs and duct paucity. Certain findings on biopsy are predictive of severe and even fatal hepatic injury, including higher degrees of necrosis, microvesicular steatosis, fibrosis, and duct reactions. In contrast, eosinophils and granulomas are associated with milder injury.&amp;lt;ref name=&amp;quot;pmid24037963&amp;quot;&amp;gt;{{cite journal| author=Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB et al.| title=Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. | journal=Hepatology | year= 2014 | volume= 59 | issue= 2 | pages= 661-70 | pmid=24037963 | doi=10.1002/hep.26709 | pmc=3946736 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24037963  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
One example of a drug-specific histological finding is centrilobular necrosis characteristic of acetaminophen hepatotoxicity.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_liver_biopsy&amp;diff=1249580</id>
		<title>Drug induced liver injury liver biopsy</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_liver_biopsy&amp;diff=1249580"/>
		<updated>2016-08-12T21:33:43Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}} {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
There are no specific liver biopsy findings diagnostic of drug induced injury, but there are several broad histological patterns that reflect the type of injury caused by the inciting drug. One exception to this is centrilobular necrosis characteristic of acetaminophen overdose.&lt;br /&gt;
&lt;br /&gt;
==Liver Biopsy==&lt;br /&gt;
The most common histological patterns seen in the drug induced liver injury network are as follows:&lt;br /&gt;
*Acute hepatitis (21%)&lt;br /&gt;
*Chronic hepatitis (14%)&lt;br /&gt;
*Cholestatic hepatitis (29%)&lt;br /&gt;
*Acute cholestasis (9%)&lt;br /&gt;
*Chronic cholestasis (10%)&lt;br /&gt;
&lt;br /&gt;
Patients presenting with hepatocellular injury tend to have evidence of severe inflammation, necrosism, hemorrhage, and rosette formation on biopsy. Patients with cholestatic injury tend to have more bile plugs and duct paucity. Certain findings on biopsy are predictive of severe and even fatal hepatic injury, including higher degrees of necrosis, microvesicular steatosis, fibrosis, and duct reactions. In contrast, eosinophils and granulomas are associated with milder injury.&amp;lt;ref name=&amp;quot;pmid24037963&amp;quot;&amp;gt;{{cite journal| author=Kleiner DE, Chalasani NP, Lee WM, Fontana RJ, Bonkovsky HL, Watkins PB et al.| title=Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations. | journal=Hepatology | year= 2014 | volume= 59 | issue= 2 | pages= 661-70 | pmid=24037963 | doi=10.1002/hep.26709 | pmc=3946736 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24037963  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1249388</id>
		<title>Drug induced liver injury natural history, complications and prognosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1249388"/>
		<updated>2016-08-11T23:21:48Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The clinical course of drug induced liver injury varies based on causative drug. General patterns are summarized below.&amp;lt;ref name=&amp;quot;pmid24879979&amp;quot;&amp;gt;{{cite journal| author=Hayashi PH, Fontana RJ| title=Clinical features, diagnosis, and natural history of drug-induced liver injury. | journal=Semin Liver Dis | year= 2014 | volume= 34 | issue= 2 | pages= 134-44 | pmid=24879979 | doi=10.1055/s-0034-1375955 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=24879979  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Natural History==&lt;br /&gt;
There is a hallmark latent period between the initiation of the drug (&amp;quot;the challenge&amp;quot;) and the development of either symptoms or, more commonly, asymptomatic elevations in serum alanine aminotransferase. Once the diagnosis of drug induced liver injury is established and the inciting drug is withdrawn, the &amp;quot;dechallenge&amp;quot; or clinical improvement is relatively immediate. Liver injury typically recurs if the drug is reintroduced in the future, often with greater severity that could be life-threatening. &lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
Up to 10% of patients with drug induced liver injury may require liver transplantation or do not survive the initial injury. Another 5-10% could be at risk for chronic liver injury, particularly if they have preexisting liver disease. Overall, complications are dependent on the inciting drug and patient [[Drug_induced_liver_injury_risk_factors|risk factors]]. &lt;br /&gt;
&lt;br /&gt;
==Prognosis==&lt;br /&gt;
Prompt withdrawal of the offending drug leads to complete resolution in 90% of patients, with no long-term sequelae. &lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1249327</id>
		<title>Drug induced liver injury natural history, complications and prognosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1249327"/>
		<updated>2016-08-11T18:42:40Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The clinical course of drug induced liver injury varies based on causative drug.&lt;br /&gt;
==Natural History==&lt;br /&gt;
There is a hallmark latent period between the initiation of the drug (&amp;quot;the challenge&amp;quot;) and the development of either symptoms or, more commonly, asymptomatic elevations in serum alanine aminotransferase. Once the diagnosis of drug induced liver injury is established and the inciting drug is withdrawn, the &amp;quot;dechallenge&amp;quot; or clinical resolution is relatively immediate. Liver injury typically recurs if the drug is reintroduced in the future, often with greater severity that could be life-threatening. &lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
==Prognosis==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1249167</id>
		<title>Drug induced liver injury natural history, complications and prognosis</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_natural_history,_complications_and_prognosis&amp;diff=1249167"/>
		<updated>2016-08-10T23:54:50Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
The clinical course of drug induced liver injury varies based on causative drug.&lt;br /&gt;
==Natural History==&lt;br /&gt;
There is a hallmark latent period between the initiation of the drug (&amp;quot;the challenge&amp;quot;) and the development of either symptoms or, more commonly, asymptomatic elevations in serum alanine aminotransferase. Once the diagnosis of drug induced liver injury is established and the inciting drug is withdrawn, the &amp;quot;dechallenge&amp;quot; or clinical resolution is relatively immediate. Liver injury often recurs if the drug is reintroduced in the future, often with greater severity that could be life-threatening. &lt;br /&gt;
&lt;br /&gt;
==Complications==&lt;br /&gt;
&lt;br /&gt;
==Prognosis==&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249166</id>
		<title>Drug induced liver injury screening</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249166"/>
		<updated>2016-08-10T23:03:51Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Screening */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
General screening guidelines for drug induced liver injury do not exist. However, certain specific guidelines have been established for drugs associated with a high incidence of severe liver injury, e.g. methotrexate.&amp;lt;ref name=&amp;quot;pmid7986233&amp;quot;&amp;gt;{{cite journal| author=Fries JF, Ramey DR, Singh G| title=Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. | journal=Arthritis Rheum | year= 1994 | volume= 37 | issue= 12 | pages= 1829-30 | pmid=7986233 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=7986233  }} &amp;lt;/ref&amp;gt; These guidelines remain controversial.&lt;br /&gt;
&lt;br /&gt;
==Screening==&lt;br /&gt;
Periodic screening of serum alanine aminotransferase is sometimes initiated for drugs associated with a high incidence of liver injury, at provider discretion.&amp;lt;ref name=&amp;quot;pmid22541696&amp;quot;&amp;gt;{{cite journal| author=Davern TJ| title=Drug-induced liver disease. | journal=Clin Liver Dis | year= 2012 | volume= 16 | issue= 2 | pages= 231-45 | pmid=22541696 | doi=10.1016/j.cld.2012.03.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=22541696  }} &amp;lt;/ref&amp;gt; An open access database of over 600 drugs implicated in liver injury can be found at http://livertox.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
However, because frequent laboratory monitoring is often not possible for both patients and providers, compliance with any drug-specific surveillance guidelines is variable and drug-specific guidelines remain controversial. This is largely because the significance of a mildly elevated serum alanine aminotransferase is unclear and may result in inappropriate drug withdrawal in patients who would otherwise adapt to ongoing use of the inciting drug.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249165</id>
		<title>Drug induced liver injury screening</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249165"/>
		<updated>2016-08-10T23:02:49Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
General screening guidelines for drug induced liver injury do not exist. However, certain specific guidelines have been established for drugs associated with a high incidence of severe liver injury, e.g. methotrexate.&amp;lt;ref name=&amp;quot;pmid7986233&amp;quot;&amp;gt;{{cite journal| author=Fries JF, Ramey DR, Singh G| title=Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. | journal=Arthritis Rheum | year= 1994 | volume= 37 | issue= 12 | pages= 1829-30 | pmid=7986233 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=7986233  }} &amp;lt;/ref&amp;gt; These guidelines remain controversial.&lt;br /&gt;
&lt;br /&gt;
==Screening==&lt;br /&gt;
Periodic screening of serum alanine aminotransferase is sometimes initiated for drugs that are specifically associated with liver injury, at provider discretion.&amp;lt;ref name=&amp;quot;pmid22541696&amp;quot;&amp;gt;{{cite journal| author=Davern TJ| title=Drug-induced liver disease. | journal=Clin Liver Dis | year= 2012 | volume= 16 | issue= 2 | pages= 231-45 | pmid=22541696 | doi=10.1016/j.cld.2012.03.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=22541696  }} &amp;lt;/ref&amp;gt; An open access database of over 600 drugs implicated in liver injury can be found at http://livertox.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
However, because frequent laboratory monitoring is often not possible for both patients and providers, compliance with any drug-specific surveillance guidelines is variable. In addition, the significance of a mildly elevated serum alanine aminotransferase is unclear and may result in inappropriate drug withdrawal in patients who would otherwise adapt to ongoing use of the inciting drug.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_prevention&amp;diff=1249164</id>
		<title>Drug induced liver injury prevention</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_prevention&amp;diff=1249164"/>
		<updated>2016-08-10T23:02:10Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Primary Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Given that many cases of drug induced liver injury are idiosyncratic, it is often not possible to prevent injury.&lt;br /&gt;
&lt;br /&gt;
==Primary Prevention==&lt;br /&gt;
Patient education on drug-drug interactions and safe dosing is recommended to prevent liver injury from known hepatotoxic drugs (e.g. acetaminophen). However, [[Drug_induced_liver_injury_screening|screening]] with routine serum alanine aminotransferase monitoring is controversial.&lt;br /&gt;
&lt;br /&gt;
==Secondary Prevention==&lt;br /&gt;
Secondary prevention strategies following drug induced liver injury include prompt withdrawal of the inciting drug, which is also the mainstay of [[Drug induced liver injury medical therapy|treatment]] for this disease.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_prevention&amp;diff=1249163</id>
		<title>Drug induced liver injury prevention</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_prevention&amp;diff=1249163"/>
		<updated>2016-08-10T23:01:25Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Primary Prevention */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Given that many cases of drug induced liver injury are idiosyncratic, it is often not possible to prevent injury.&lt;br /&gt;
&lt;br /&gt;
==Primary Prevention==&lt;br /&gt;
Patient education on drug-drug interactions and safe dosing is recommended to prevent liver injury from known hepatotoxic drugs (e.g. acetaminophen). However, [[http://www.wikidoc.org/index.php/Drug_induced_liver_injury_screening|screening]] with routine serum alanine aminotransferase monitoring is controversial.&lt;br /&gt;
&lt;br /&gt;
==Secondary Prevention==&lt;br /&gt;
Secondary prevention strategies following drug induced liver injury include prompt withdrawal of the inciting drug, which is also the mainstay of [[Drug induced liver injury medical therapy|treatment]] for this disease.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_prevention&amp;diff=1249162</id>
		<title>Drug induced liver injury prevention</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_prevention&amp;diff=1249162"/>
		<updated>2016-08-10T23:00:33Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Given that many cases of drug induced liver injury are idiosyncratic, it is often not possible to prevent injury.&lt;br /&gt;
&lt;br /&gt;
==Primary Prevention==&lt;br /&gt;
Patient education on drug-drug interactions and safe dosing is recommended to prevent liver injury from known hepatotoxic drugs (e.g. acetaminophen). However, screening with routine serum alanine aminotransferase monitoring is controversial. &lt;br /&gt;
&lt;br /&gt;
==Secondary Prevention==&lt;br /&gt;
Secondary prevention strategies following drug induced liver injury include prompt withdrawal of the inciting drug, which is also the mainstay of [[Drug induced liver injury medical therapy|treatment]] for this disease.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249161</id>
		<title>Drug induced liver injury screening</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249161"/>
		<updated>2016-08-10T22:54:19Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
General screening guidelines for drug induced liver injury do not exist. However, certain specific guidelines have been established for drugs associated with a high incidence of severe liver injury, e.g. methotrexate.&amp;lt;ref name=&amp;quot;pmid7986233&amp;quot;&amp;gt;{{cite journal| author=Fries JF, Ramey DR, Singh G| title=Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. | journal=Arthritis Rheum | year= 1994 | volume= 37 | issue= 12 | pages= 1829-30 | pmid=7986233 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=7986233  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Screening==&lt;br /&gt;
Periodic screening of serum alanine aminotransferase is sometimes initiated for drugs that are specifically associated with liver injury, at provider discretion.&amp;lt;ref name=&amp;quot;pmid22541696&amp;quot;&amp;gt;{{cite journal| author=Davern TJ| title=Drug-induced liver disease. | journal=Clin Liver Dis | year= 2012 | volume= 16 | issue= 2 | pages= 231-45 | pmid=22541696 | doi=10.1016/j.cld.2012.03.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=22541696  }} &amp;lt;/ref&amp;gt; An open access database of over 600 drugs implicated in liver injury can be found at http://livertox.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
However, because frequent laboratory monitoring is often not possible for both patients and providers, compliance with any drug-specific surveillance guidelines is variable. In addition, the significance of a mildly elevated serum alanine aminotransferase is unclear and may result in inappropriate drug withdrawal in patients who would otherwise adapt to ongoing use of the inciting drug.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249160</id>
		<title>Drug induced liver injury screening</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_screening&amp;diff=1249160"/>
		<updated>2016-08-10T22:52:27Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}}; {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
General screening guidelines for drug induced liver injury do not exist. However, certain specific guidelines have been established for drugs associated with severe injury, e.g. methotrexate.&amp;lt;ref name=&amp;quot;pmid7986233&amp;quot;&amp;gt;{{cite journal| author=Fries JF, Ramey DR, Singh G| title=Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. | journal=Arthritis Rheum | year= 1994 | volume= 37 | issue= 12 | pages= 1829-30 | pmid=7986233 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=7986233  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Screening==&lt;br /&gt;
Periodic screening of serum alanine aminotransferase is sometimes initiated for drugs that are specifically associated with liver injury, at provider discretion.&amp;lt;ref name=&amp;quot;pmid22541696&amp;quot;&amp;gt;{{cite journal| author=Davern TJ| title=Drug-induced liver disease. | journal=Clin Liver Dis | year= 2012 | volume= 16 | issue= 2 | pages= 231-45 | pmid=22541696 | doi=10.1016/j.cld.2012.03.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=22541696  }} &amp;lt;/ref&amp;gt; An open access database of over 600 drugs implicated in liver injury can be found at http://livertox.nih.gov/.&lt;br /&gt;
&lt;br /&gt;
However, because frequent laboratory monitoring is often not possible for both patients and providers, compliance with any drug-specific surveillance guidelines is variable. In addition, the significance of a mildly elevated serum alanine aminotransferase is unclear and may result in inappropriate drug withdrawal in patients who would otherwise adapt to ongoing use of the inciting drug.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
	<entry>
		<id>https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_physical_examination&amp;diff=1249159</id>
		<title>Drug induced liver injury physical examination</title>
		<link rel="alternate" type="text/html" href="https://www.wikidoc.org/index.php?title=Drug_induced_liver_injury_physical_examination&amp;diff=1249159"/>
		<updated>2016-08-10T22:47:22Z</updated>

		<summary type="html">&lt;p&gt;Rachita Navara: /* Overview */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;__NOTOC__&lt;br /&gt;
{{Drug induced liver injury}}&lt;br /&gt;
{{CMG}} {{AE}} {{rachita}}&lt;br /&gt;
&lt;br /&gt;
==Overview==&lt;br /&gt;
Patients with drug induced liver injury usually appear normal on physical exam, unless they are presenting in acute liver failure. &amp;lt;ref name=&amp;quot;pmid22541696&amp;quot;&amp;gt;{{cite journal| author=Davern TJ| title=Drug-induced liver disease. | journal=Clin Liver Dis | year= 2012 | volume= 16 | issue= 2 | pages= 231-45 | pmid=22541696 | doi=10.1016/j.cld.2012.03.002 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=22541696  }} &amp;lt;/ref&amp;gt; Some patients may also present in chronic liver failure due to rare drugs associated with liver scarring, e.g. methotrexate.&amp;lt;ref name=&amp;quot;pmid7986233&amp;quot;&amp;gt;{{cite journal| author=Fries JF, Ramey DR, Singh G| title=Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by Kremer et al. | journal=Arthritis Rheum | year= 1994 | volume= 37 | issue= 12 | pages= 1829-30 | pmid=7986233 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;amp;tool=sumsearch.org/cite&amp;amp;retmode=ref&amp;amp;cmd=prlinks&amp;amp;id=7986233  }} &amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
==Physical Examination==&lt;br /&gt;
===General Appearance===&lt;br /&gt;
The general appearance of the patient will depend on the severity of the condition.&lt;br /&gt;
===Vital Signs===&lt;br /&gt;
The patient may be febrile.&lt;br /&gt;
===Skin===&lt;br /&gt;
The skin may be jaundiced. THere may also be excoriations from pruritis due to drug induced cholestatic injury.&lt;br /&gt;
===Abdomen===&lt;br /&gt;
There may be right upper quadrant tenderness. There may be ascites in cases of chronic drug induced liver injury.&lt;br /&gt;
===Extremities===&lt;br /&gt;
There may be stigmata of chronic drug induced liver injury including cachexia, spider angiomata and palmar erythema.&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist|2}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Hepatology]]&lt;/div&gt;</summary>
		<author><name>Rachita Navara</name></author>
	</entry>
</feed>